My collection
403 clinical trials, 243 products, 63 drugs, 3 abstracts, 288 clinical trial arms
Drug fulvestrantIndication:Endometrial Cancer,Ovarian Cancer,Breast Cancer,Target:Estrogen Receptor,Abstract:A phase 1 dose expan...,First-line inavolisi..., Search all connections |
Drug PARPi |
Clinical trial HRDref-WGSA Collaborative Project Aimed to Establish a WGS-based Reference Standard for Evaluating the Analytical Performance of HRD Status Testing |
Clinical trial 2024-TJ-OCBiomarkerA Biomarker Exploration Study of Precision Treatment in Ovarian Cancer |
Clinical trial JiangsuCHENG001A Prospective, Single-arm, Multicenter, Exploratory Phase II Study to Evaluate the Efficacy and Safety of Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer Organization:Wenjun Cheng,Product:Anlotinib,Indication:Ovarian Cancer,Fallopian Tube Neopl...,Neoplasms by Site, Search all connections |
Clinical trial MC220602Phase 1 Clinical Trial Using Autologous, MUC1-Activated T Cells Expanded From Peripheral Blood in Patients With Relapsed and Resistant Ovarian Cancer Organization:Mayo Clinic,Product:Autologous MUC1-acti...,Indication:Platinum-Resistant F...,Platinum-Resistant O...,Platinum-Resistant P..., Search all connections |
Clinical trial PROM-2301A Phase 2A Multicenter, Open Label Study of Promitil for the Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After First Line Therapy |
Clinical trial 2023-508260-30-01A Pragmatic Randomized Phase III Trial to Assess the Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery |
Clinical trial 2024 NO. 049An Exploratory Clinical Study of Statins for Improving Chemotherapy and Maintenance in Patients With Ovarian Cancer: a Prospective, Multicenter Clinical Study |
Clinical trial 27T51-01A Phase 1a/1b Study of 27T51, an Anti-MUC16 CAR T Cell Drug Product Administered Alone or in Combination for Participants With Recurrent or Refractory Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Organization:Regeneron Pharmaceut...,Product:Cemiplimab,Indication:Ovarian Cancer,Primary Peritoneal C...,Fallopian tube cance...,Drug:Atezolizumab, Search all connections |
Abstract https://ascopubs.org/doi/10.1200/JCO.2023.41.16_suppl.5505Clinical trial:VB-111-701/GOG-3018,Indication:Ovarian Cancer,Product:paclitaxel + ofraner...,Paclitaxel,Drug:Tiragolumab,Ofranergene obadenov..., Search all connections |
Abstract https://www.nejm.org/doi/full/10.1056/NEJMoa2309169Clinical trial:IMGN853-0416,Indication:Ovarian Cancer,Product:Mirvetuximab Soravta...,Drug:Mirvetuximab soravta..., Search all connections |
Clinical trial SGNMesoC2-001A Phase 1 Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of SGN-MesoC2 in Subjects With Advanced Solid Tumors |
Clinical trial LOXO-LNC-24001A Phase 1a/1b Study of LY4052031, an Antibody-Drug Conjugate Targeting Nectin-4, in Participants With Advanced or Metastatic Urothelial Carcinoma or Other Solid Tumors Organization:Eli Lilly and Compan...,Product:LY4052031,Indication:Metastatic Solid Tum...,Recurrent Solid Tumo...,Advanced Solid Tumor, Search all connections |
Clinical trial ALISON-UMCG-01An Open Label, Phase 1 Study to Evaluate the Safety, Feasibility and Immunogenicity of an Allogeneic, Cell-based Vaccine (DCP-001) in High Grade Serous Ovarian Cancer Patients After Primary Treatment |
Clinical trial PHN-010-001First-in-Human, Phase 1b Study of PHN-010, an Antibody Drug Conjugate, in Patients With Advanced Solid Tumors Organization:Pheon Therapeutics,Product:PHN-010,Indication:lung cancer,Colon Cancer,Endometrial Cancer, Search all connections |
Clinical trial NCI-2014-01984A Phase 1 Trial of MK-3475 Plus Ziv-Aflibercept in Patients With Advanced Solid Tumors Organization:National Cancer Inst...,Drug:mFOLFOX6,Indication:Stage IV Cutaneous M...,Colorectal cancer,Metastatic Malignant..., Search all connections |
Clinical trial 180049A Phase II Study Using the Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in Patients With Metastatic Cancer Organization:National Cancer Inst...,Drug:cyclophosphamide,Indication:Endocrine Tumors,Ovarian Cancer,Breast Cancer, Search all connections |
Clinical trial 2018-126Phase II Study of ONC201 Plus Weekly Paclitaxel in Patients With Platinum-Resistant Refractory or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Organization:Ira Winer,Product:Akt/ERK Inhibitor ON...,Indication:Ovarian Cancer,Platinum-Resistant F...,Platinum-Resistant O..., Search all connections |
Clinical trial ISPY-P1.01ISPY-P1.01: Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer: A Phase I/Ib Trial Organization:QuantumLeap Healthca...,Product:Vic-trastuzumab duoc...,Indication:Breast Cancer (HER2-...,HER2 low,SYD-985, Search all connections |
Clinical trial 160131A Phase I/II Study Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to Patients With CD70-Expressing Cancers Organization:National Cancer Inst...,Drug:cyclophosphamide,fludarabine,Indication:Pancreatic Cancer,Renal Cell Cancer,Breast Cancer, Search all connections |
Clinical trial STUDY-23-00832A Single-Center, Open-Label, Single-Arm, Phase I Study With Dose Expansion Cohort of Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer Organization:Icahn School of Medi...,Product:Sacituzumab,Indication:Ovarian Cancer,Uterine Cancer,Drug:Cisplatin, Search all connections |
Clinical trial CA052-002A Phase 1/2 Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors Organization:Bristol-Myers Squibb,Product:BMS-986340,Indication:Cervical Cancer,Gastric/Gastroesopha...,Colorectal Cancer, Search all connections |
Clinical trial 30102012Phase Ib Study of Metformin in Combination With Carboplatin/Paclitaxel Chemotherapy in Patients With Advanced Ovarian Cancer |
Clinical trial AnhuiCancerAn Exploratory Clinical Study of Neoadjuvant Therapy With Pamiparib Combined With Surufatinib for Advanced Ovarian Cancer: A Single-arm, Prospective, Single-center Clinical Study |
Clinical trial MS201924_0002An Open-label, Multicenter, Randomized Phase 2 Study of the ATR Inhibitor Tuvusertib in Combination With the PARP Inhibitor Niraparib or the ATM Inhibitor Lartesertib in Participants With BRCA Mutant and/or Homologous Recombination deficiency (HRD)-Positive Epithelial Ovarian Cancer That Progressed on Prior PARP Inhibitor Therapy (DDRiver EOC 302) Organization:EMD Serono Research ...,Product:Tuvusertib,Lartesertib,Indication:Ovarian Cancer,Drug:Atezolizumab, Search all connections |
Clinical trial I240An Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer Organization:Canadian Cancer Tria...,Drug:AN0025,Indication:Ovarian Cancer,Product:BA3011,BA3021,To be determined, Search all connections |
Clinical trial 22-0384.ccA Phase II Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib in Recurrent Platinum Sensitive Ovarian, Peritoneal, and Fallopian Tube Cancer Organization:University of Colora...,Product:Mirvetuximab Soravta...,Indication:Ovarian Cancer,Peritoneal Cancer,Fallopian tube cance...,Drug:olaparib, Search all connections |
Clinical trial 190143A Phase II Study Using the Administration of Autologous T-Cells Engineered Using the Sleeping Beauty Transposon/Transposase System to Express T-Cell Receptors Reactive Against Mutated Neoantigens in Patients With Metastatic Cancer Organization:National Cancer Inst...,Drug:fludarabine,cyclophosphamide,IL-2,Indication:Endocrine/Neuroendoc...,Breast Cancer,Gastrointestinal/Gen..., Search all connections |
Clinical trial 2018-0680A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors Organization:M.D. Anderson Cancer...,Product:TRPV6 Calcium Channe...,Indication:Malignant Neoplasm,Malignant Solid Neop...,Ovarian Cancer, Search all connections |
Clinical trial 5150302Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer |
Clinical trial Guard-05A Study of Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen With Risk Factors:A Single-Arm, Multicenter Clinical Trial Organization:Shandong University,Product:Efbemalenograstim,Indication:Ovarian Cancer,Cervical Cancer, Search all connections |
Clinical trial CHT101A Phase I Clinical Study to Assess the Safety and Efficacy of CD70-targeted CAR-T in the Treatment of CD70-positive Refractory or Relapsed Solid Tumors Organization:Zhejiang University,Product:CHT101,Indication:Metastatic Tumor,Advanced Solid Tumor,Renal Cell Carcinoma, Search all connections |
Clinical trial CCRG19-001First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients Organization:University Hospital ...,Product:IL15-transpresenting...,Indication:Esophageal cancer,Pancreatic Cancer,Ovarian Cancer, Search all connections |
Clinical trial D926UC00001A Phase II, Multicentre, Open-label, Master Protocol to Evaluate the Efficacy and Safety of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Combination With Anticancer Agents in Patients With Advanced/Metastatic Solid Tumours Organization:AstraZeneca,Product:Datopotamab deruxtec...,Indication:Endometrial Cancer,Stomach Cancer,Metastatic Castratio..., Search all connections |
Clinical trial 2017/1168IMPACT: A Phase 0 Randomized Window-of-Opportunity Study of Novel and Repurposed Therapeutic Agents in Women Triaged to Primary Surgery for Advanced Epithelial Ovarian Cancer in Stages IIIa - IV. |
Clinical trial CASE1824The Feasibility, Safety, and Clinical Outcomes of Fasting During Neoadjuvant Chemotherapy in Patients With Epithelial Ovarian Cancer |
Clinical trial Pemb-HTPembrolizumab in Small Cell Carcinoma of Ovary - Hypercalcemic Type Patient (Pemb-HT) Organization:University Health Ne...,Drug:mFOLFOX6,Indication:Small Cell Lung Canc...,Hypercalcaemic Type,Ovarian Cancer, Search all connections |
Clinical trial 11-128A PHASE 1-2 NEOADJUVANT DOSE FINDING, SAFETY, AND IMMUNOLOGIC EFFICACY TRIAL OF INTENSIVE LOCOREGIONAL CHEMOIMMUNOTHERAPY FOR RECURRENT OVARIAN CANCER AND TUMOR-SPECIFIC INTRANODAL AUTOLOGOUS ALPHA-DC1 VACCINES Organization:Roswell Park Cancer ...,Product:Cisplatin + Celecoxi...,Cisplatin + CKM + Ce...,Indication:Ovarian Cancer,Cancer,Ovarian, Search all connections |
Product UCB4594 |
Clinical trial CRUKD/24/001A Cancer Research UK Phase I/II Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of UCB4594 Alone and in Combination With Anti-cancer Treatments in Participants With Advanced Malignancies Organization:Cancer Research UK,Product:UCB4594,Indication:Advanced Solid Tumou...,Squamous Cell Carcin...,cancer, Search all connections |
Clinical trial STUDY00022229An Early Phase I Study of the Pharmacodynamics of WEE1 Inhibitor, ZN-c3, in Metastatic Solid Tumors Organization:OHSU Knight Cancer I...,Product:Wee1 Inhibitor ZN-c3,Indication:Fallopian Tube Carci...,Ovarian Cancer,Advanced Primary Per..., Search all connections |
Clinical trial TSCAN-002A Phase 1 Basket Study Evaluating the Safety and Feasibility of T-Plex, Autologous Customized T Cell Receptor-Engineered T Cells Targeting Multiple Peptide/HLA Antigens in Participants With Antigen-positive Locally Advanced (Unresectable) or Metastatic Solid Tumors |
Clinical trial 22.0392Combination Therapy With Liposomal Doxorubicin and Withaferin A (Ashwagandha, ASWD) in Recurrent Ovarian Cancer |
Clinical trial SON-DP-A001-STA First-in-Human (FIH), Open-Label, Phase Ia/Ib Dose Escalation and Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SON-DP in Participants With Relapsed/Metastatic Solid Tumors |
Clinical trial LACOG 1018Palbociclib Plus Letrozole Treatment After Progression to Second Line Chemotherapy for Women With ER/PR-positive Ovarian Cancer Organization:Latin American Coope...,Product:Palbociclib,Letrozole,Indication:Ovarian Cancer,Clinical trial arm:Letrozole + Palbocic...,Abstract:A phase II trial of ..., Search all connections |
Clinical trial XmAb808-01A Phase 1, First-in-Human, Dose-Finding and Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Activity of XmAb®808 in Combination With Pembrolizumab in Selected Advanced Solid Tumors |
Clinical trial OVHM-01A Phase I/II Trial of Intraperitoneal (IP) Cisplatin Combined With IV Paclitaxel in Patients With Epithelial Ovarian Cancer Optimally Debulked at Their Initial Surgery Performed Following Neoadjuvant Intravenous Chemotherapy |
Clinical trial 2020-0165Laparoscopic Cytoreduction After Neoadjuvant Chemotherapy Organization:M.D. Anderson Cancer...,Drug:AN0025,Indication:Ovarian Cancer,Ovarian Clear Cell A...,Endometrioid Tumor, Search all connections |
Clinical trial SCST-01A Multicenter, Prospective, Randomized Trial Comparing Paclitaxel and Carboplatin or Bleomycin, Etoposide and Cisplatin in the Treatment of Ovarian Malignant Sex Cord-Stromal Tumors Organization:Beihua Kong,Drug:Tiragolumab,AN0025,Cisplatin,Indication:Ovarian Sex Cord Str...,Ovarian Cancer,Product:Bleomycin,Etoposide, Search all connections |
Clinical trial AK104-IIT-003Efficacy and Safety of AK104 (PD-1/CTLA-4 Bispecific Antibody) Combined With Chemotherapy as Neoadjuvant Treatment for Advanced Ovarian Cancer: a Single-arm, Open-label, Multicenter Clinical Study Organization:Hunan Cancer Hospita...,Product:AK104,Indication:Ovarian Cancer,Abstract:An open, prospective..., Search all connections |
Clinical trial 20-357Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Ovarian, Fallopian Tube, and Peritoneal Cancer Organization:Dana-Farber Cancer I...,Product:Microdevice,Indication:Ovarian Cancer,Fallopian tube cance...,Peritoneal Cancer, Search all connections |
Clinical trial 18070604A Study of Serum Folate Levels in Patients Treated With Olaparib Organization:Rush University Medi...,Product:Folic Acid,Indication:Ovarian Cancer,Breast Cancer,Folic Acid Deficienc..., Search all connections |
Clinical trial 826085 (UPCC 02916)Phase I Study of Human Chimeric Antigen Receptor Modified T Cells in Patients With Mesothelin Expressing Cancers Organization:University of Pennsy...,Product:huCART-meso,Indication:Adenocarcinoma of th...,Ovarian Cancer,Peritoneal Cancer, Search all connections |
Clinical trial IB2016-02Trabectedin Combined With Durvalumab (MEDI4736) in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas. A Phase Ib Study. Organization:Institut Bergonié,Product:Trabectedin + Durval...,Indication:Ovarian Cancer,Soft Tissue Sarcoma, Search all connections |
Clinical trial RG1005140Phase IB Trial of Niraparib and TSR-042 in Patients With BRCA-Mutated Breast, Pancreas or Ovary Cancer Organization:University of Washin...,Drug:Atezolizumab,Indication:Breast Cancer,Breast Cancer, Stage...,BRCA-Associated Mali..., Search all connections |
Clinical trial Zhongda-HospitalReal-world Data From a Multi-center Study: Insights to the Effectiveness and Safety in Patients With Ovarian Cancer Receiving Niraparib as First-line Maintenance Therapy |
Clinical trial OLIVIA-UMCG-01Ovarian Cancer Treatment With a Liposome Formulated mRNA Vaccine in Combination With (Neo-)Adjuvant Chemotherapy |
Clinical trial 2020-000825-18An Open-label, Multicentric, Phase Ib/II Study to Assess the Safety and Efficacy of AsiDNATM, a DNA Repair Inhibitor, Administered Intravenously in Addition to Niraparib in Patients With Relapsed Platinum Sensitive Ovarian Cancer Already Treated With Niraparib Since at Least 6 Months Organization:Gustave Roussy, Canc...,Product:AsiDNA,Rucaparib,Indication:Ovarian Cancer,Drug:Atezolizumab,olaparib, Search all connections |
Clinical trial [123I]I-DARPIN-Ec1SPECT Imaging of EpCAM Receptors Using [123I]I-DARPIN-Ec1 in Lung and Ovarian Cancers Patients Organization:Tomsk National Resea...,Product:[123I]I-DARPIN-Ec1,Indication:lung cancer,Ovarian Cancer, Search all connections |
Clinical trial NOGGO-ov53A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy (N-Plus) Organization:North Eastern German...,Product:3 cycles chemotherap...,6 cycles chemotherap...,Indication:Ovarian Cancer,Fallopian tube cance...,Primary Peritoneal C...,Abstract:First trial of chemo..., Search all connections |
Clinical trial MOGCT-01A Multicenter, Prospective, Randomized Trial Comparing Paclitaxel and Carboplatin or Bleomycin, Etoposide and Cisplatin in the Treatment of Malignant Ovarian Germ Cell Tumors Organization:Beihua Kong,Drug:Tiragolumab,AN0025,Cisplatin,Indication:Ovarian Germ Cell Ca...,Ovarian Cancer,Product:Bleomycin,Etoposide, Search all connections |
Clinical trial IIT-2017-HIPEC-OvarianHeated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients Organization:Andrea Jewell,Drug:AN0025,Tiragolumab,Indication:Ovarian Cancer,Fallopian tube cance..., Search all connections |
Clinical trial UCL/17/0629Phase II Trial of Maintenance Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal Cancer Organization:University College L...,Drug:mFOLFOX6,Indication:Ovarian Cancer,Fallopian tube cance...,Peritoneal Cancer, Search all connections |
Clinical trial 170517ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK |
Clinical trial NCI-2009-01057A Phase I Dose-Escalation Study of Oral ABT-888 (NSC #737664) Plus Intravenous Irinotecan (CPT-11, NSC#616348) Administered in Patients With Advanced Solid Tumors Organization:National Cancer Inst...,Product:Irinotecan,Indication:Malignant Neoplasm,Hodgkin lymphoma,Metastatic Malignant..., Search all connections |
Clinical trial ZZITICI-004A Phase II/III Trial of Comparison of Benefit of Administration of Checkpoint Inhibitors Plus Chemodrug Via Artery or Fine Needle to Tumor Versus Vein for Immunotherapy of Advanced Solid Tumors Organization:Second Affiliated Ho...,Product:Pembrolizumab,Indication:hepatocellular carci...,lung cancer,Melanoma, Search all connections |
Clinical trial CRUKD/22/002HMBD-001 (an Anti-HER3 Monoclonal Antibody) Given Intravenously as a Single Agent and in Combination in Patients With Advanced HER3 Positive Solid Tumours Organization:Cancer Research UK,Product:HMBD-001,Indication:Bladder Cancer,Triple-Negative Brea...,Castration-resistant..., Search all connections |
Clinical trial OU-SCC-PTC-001Phase 1B Trial With Unesbulin in High-Grade Serous Ovarian Cancer: a Targeted Approach Toward Chemoresistant Stem-Like Cancer Cells |
Clinical trial I 248613A Phase I/IIb Study of DEC205mAb-NY-ESO-1 Fusion Protein (CDX-1401) Given With Adjuvant Poly-ICLC in Combination With INCB024360 for Patients in Remission With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma Whose Tumors Express NY-ESO-1 or LAGE-1 Antigen Organization:Roswell Park Cancer ...,Product:DEC-205/NY-ESO-1 Fus...,Epacadostat,Poly ICLC,Indication:fallopian tube carci...,Ovarian Cancer,Primary Peritoneal C..., Search all connections |
Product ETX-19477 |
Clinical trial 2017-0422A Phase I Study of TAK-659 and Paclitaxel in Patients With Advanced Solid Tumors Organization:M.D. Anderson Cancer...,Product:Mivavotinib,Indication:Malignant Neoplasm,Ovarian Cancer,Malignant Solid Neop...,Drug:Tiragolumab,Abstract:A phase I study of T..., Search all connections |
Clinical trial ETX-19477-101A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies Organization:858 Therapeutics,Product:ETX-19477,Indication:Advanced or Metastat...,Breast Cancer,Ovarian Cancer, Search all connections |
Product Nab-Paclitaxel + CarboplatinIndication:Ovarian Cancer,Epithelial Ovarian C...,Fallopian tube carci...,Clinical trial:IRB-20230058-R, Search all connections |
Clinical trial ZZICI3-015Triplex CTLA4/PD1/PDL1 Checkpoint Inhibitors Combination Therapy for Advanced Solid Tumors Organization:Second Affiliated Ho...,Product:Ipilimumab + Pembrol...,Indication:lung cancer,Liver Cancer,Colorectal Cancer, Search all connections |
Clinical trial IRB-20230058-RNab-paclitaxel Versus Solvent-based Taxanes As First-Line Treatment for Patients With Advanced Ovarian Cancer Organization:Women's Hospital Sch...,Product:Nab-Paclitaxel + Car...,Indication:Ovarian Cancer,Epithelial Ovarian C...,Fallopian tube carci..., Search all connections |
Clinical trial GY1721T-cell Therapy in Combination With Checkpoint Inhibitors for Patients With Advanced Ovarian-, Fallopian Tube- and Primary Peritoneal Cancer Organization:Inge Marie Svane,Drug:cyclophosphamide,fludarabine,interleukin-2,Indication:Ovarian Cancer,Product:TIL, Search all connections |
Clinical trial 2017-004197-34An Open-label Phase 1 of Pembrolizumab in Combination With Bevacizumab and Pegylated Liposomal Doxorubicin in Patients With Platinum Resistant Epithelial Ovarian Cancer Organization:Gustave Roussy, Canc...,Drug:mFOLFOX6,Atezolizumab,Indication:Ovarian Cancer,Product:Pegylated Liposomal ...,Abstract:Bevacizumab exposure..., Search all connections |
Clinical trial NU 22MH03Phase II Open-Label Multi-Cohort Study Evaluating CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Patients With Advanced Chemorefractory Colorectal, Pancreatic, or Other Solid Cancers Organization:Northwestern Univers...,Drug:Devimistat,Indication:Cholangiocarcinoma,Colorectal Cancer,Gastroesophageal Jun..., Search all connections |
Clinical trial GETHI 2016-01Open Label Phase II Clinical Trial of Enzalutamide in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors: GreKo III Study |
Clinical trial ACE-106-001A Phase I/II, Open-label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Ascending Doses of ACE-86225106 as Monotherapy in Patients With Advanced Solid Tumors |
Clinical trial STAPOVERSignal TrAnsduction Pathway Activity Analysis in OVarian cancER Organization:Gynaecologisch Oncol...,Product:Letrozole,Bicalutamide,Everolimus,Indication:Ovarian Cancer,Signal Transduction ...,therapy-associated c..., Search all connections |
Clinical trial 7405-20A Phase II, Open Lable, Single Arm, Trial to Determine Efficacy and Safety of Lenvatinib in Combination With Pembrolizumab for Platinum- Sensitive Recurrent Ovarian Cancer Organization:Sheba Medical Center,Drug:mFOLFOX6,Indication:Ovarian Cancer,cancer,Epithelial Ovarian C..., Search all connections |
Clinical trial MITO-7Weekly Versus Every 3 Week Carboplatin and Paclitaxel in Patients With Ovarian Cancer: a Phase III Randomized Multicenter Study |
Clinical trial AA1809Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors |
Clinical trial STU-2019-0769Pre-Surgical Window Pilot Investigation of the Effect of PARP Inhibition on the Cellular and Molecular Changes in Primary Ovarian and Breast Cancer |
Clinical trial UCSD 807804A Phase I Trial of Intraperitoneal LSTA1 in Patients Undergoing Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancy Organization:University of Califo...,Product:CRS-HIPEC + LSTA1,Indication:Colorectal Cancer,Ovarian Cancer,appendiceal cancer, Search all connections |
Clinical trial PT 1491A Non-randomized Control Study Comparing Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer |
Clinical trial MITO-2Phase III Randomized Multicentre Trial of Carboplatin + Liposomal Doxorubicin vs Carboplatin + Paclitaxel in Patients With Ovarian Cancer Organization:National Cancer Inst...,Product:Liposomal Doxorubici...,Indication:Ovarian Cancer,Drug:PD-1 antibody,paclitaxel, Search all connections |
Clinical trial EORTC-1508A Phase II Study of the Anti-PDL1 Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid to Investigate Safety and Efficacy of This Combination in Recurrent Platinum-resistant Ovarian, Fallopian Tube or Primary Peritoneal Adenocarcinoma Organization:European Organisatio...,Drug:Atezolizumab,Aspirin,placebo,Indication:Ovarian Cancer,Product:atezolizumab, Search all connections |
Clinical trial 22-049Perioperative Stress Reduction in Ovarian Cancer (PRESERVE Trial)-A Prospective Randomized Pilot Study Organization:Memorial Sloan Kette...,Product:Propranolol,Indication:Ovarian Cancer,Stage II Ovarian Can...,Stage III Ovarian Ca..., Search all connections |
Clinical trial MITO-16 -MANGO-OV2bMulticenter Phase III Randomized Study With Second Line Chemotherapy Plus or Minus Bevacizumab in Patients With Platinum Sensitive Epithelial Ovarian Cancer Recurrence After a Bevacizumab/Chemotherapy First Line Organization:National Cancer Inst...,Drug:Atezolizumab,Tiragolumab,AN0025,Indication:Ovarian Cancer, Search all connections |
Clinical trial 20160477Phase II Single Arm Study of Combination Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Ovarian, Fallopian Tube, or Peritoneal Carcinoma Receiving Neoadjuvant Chemotherapy Organization:University of Miami,Drug:mFOLFOX6,Tiragolumab,AN0025,Indication:Fallopian tube cance...,Peritoneal Cancer,Ovarian Cancer, Search all connections |
Clinical trial P420_PARPReal World Data Analysis of PARP Inhibitors Use in Patients With Ovarian Cancer |
Clinical trial EudraCT: 2021-000244-21MITO 35a: A Multicenter, Prospective, Single Arm Trial of Olaparib Maintenance Therapy in Newly Diagnosed BRCA Wildtype Advanced Ovarian, Fallopian Tube and Primitive Peritoneal Cancer |
Clinical trial MITO-16 - MANGO-OV2A MULTICENTER STUDY IN PATIENTS WITH STAGE III-IV EPITHELIAL OVARIAN CANCER TREATED WITH CARBOPLATIN/PACLITAXEL WITH BEVACIZUMAB: CLINICAL AND BIOLOGICAL PROGNOSTIC FACTORS Organization:National Cancer Inst...,Drug:Atezolizumab,Tiragolumab,AN0025,Indication:Ovarian Cancer, Search all connections |
Clinical trial PBC038A Phase I Clinical Study of CD70-targeting CAR-T Therapy in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors Organization:Weijia Fang,Product:CD70 CAR-T cells,Indication:Metastatic Tumor,Advanced Solid Tumor,Renal Cell Carcinoma, Search all connections |
Clinical trial 2023(01)Efficacy and Safety of Huaier Granule in Patients With Stage I Primary Ovarian Fallopian Tube Cancer After Peritoneal Cancer: a Single-center Prospective Single-arm Study Organization:Ruijin Hospital,Product:Huaier,Indication:Ovarian Cancer,Fallopian tube cance...,Peritoneal Cancer, Search all connections |
Clinical trial MMOT imaging89Zr-MMOT0530A PET Imaging in Patients With Unresectable Pancreatic or Platinum-resistant Ovarian Cancer Before Treatment With DMOT4039A. A Separate Study to the Phase I Study Protocol DMO4993g Organization:University Medical C...,Product:89Zr-MMOT0530A,Indication:Ovarian Cancer,Ovarian Diseases,Adnexal Diseases, Search all connections |
Clinical trial 17-382A Phase 1 Study of Durvalumab, Tremelimumab and Radiotherapy in Recurrent Gynecologic Cancer Organization:Dana-Farber Cancer I...,Drug:AN0025,Indication:Recurrent Gynecologi...,cervical cancer,Ovarian Cancer, Search all connections |
Clinical trial MITO28 / MaNGO ov4A Phase II Clinical Trial of Pembrolizumab in Combination With Carboplatin-paclitaxel in Patients With Advanced (Stage III B-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer: MITO28/MANGO OV4 Study |
Clinical trial 15-247A Phase I Study of Concomitant WT1 Analog Peptide Vaccine or NY-ESO-1 Overlapping Peptides Vaccine in Combination With Nivolumab in Patients With Recurrent Ovarian Cancer Who Are in Second or Greater Remission Organization:Memorial Sloan Kette...,Product:WT1,NY-ESO-1 Vaccine,Indication:Ovarian Cancer,fallopian tube,Primary Peritoneal C...,Drug:T-VEC, Search all connections |
Clinical trial IRB-2022-674NKG2D CAR-NK Cell Therapy for Patients With Platinum-Resistant Recurrent Ovarian Cancer |
Clinical trial 2018-0663Fecal Microbiota Transplantation (FMT) for Immune-Checkpoint Inhibitor Induced-Diarrhea/Colitis in Genitourinary Cancer Patients Organization:M.D. Anderson Cancer...,Product:Loperamide,Indication:Colitis,Diarrhea,Malignant Genitourin..., Search all connections |
Clinical trial UPCC# 03821, IND #27590Phase 1 Trial of Human Chimeric Antigen Receptor Modified T Cells (huCART-meso) Administered in Combination With VCN-01 in Patients With Pancreatic and Serous Epithelial Ovarian Cancer Organization:University of Pennsy...,Drug:VCN-01,Indication:Pancreatic Cancer,Ovarian Cancer,Product:huCART-meso, Search all connections |
Clinical trial BRCA ScreeningCapturing BRCA1/2 Mutational Status in Women With High Grade Serous Ovarian Cancer and Impact on Clinical Outcome. |
Clinical trial 201612723Nicotinamide Riboside (NR) in Paclitaxel-induced Peripheral Neuropathy Organization:Donna Hammond, PhD,Product:Nicotinamide Ribosid...,Indication:Peripheral neuropath...,Breast Cancer Metast...,Ovarian Cancer, Search all connections |
Clinical trial LCCC2152-ATLAdministration of T Cells Expressing B7-H3 Specific Chimeric Antigen Receptors (CAR) and Containing the Inducible Caspase 9 Safety Switch in Subjects With Recurrent Platinum Resistant Epithelial Ovarian Cancer Organization:UNC Lineberger Compr...,Product:iC9-CAR.B7-H3 T cell...,Indication:Ovarian Neoplasm,Ovarian Cancer,Recurrent,Drug:cyclophosphamide,fludarabine, Search all connections |
Clinical trial B2022-348-01Pamiparib in Combination With Surufatinib in Patients With Platinum-resistant Ovarian Cancer Who Received Prior Poly (ADP-ribose) Polymerase (PARP) Inhibitors: a Multicenter, Single-arm, Phase Ib/II Trial Organization:Sun Yat-sen Universi...,Drug:Pamiparib,Tiragolumab,Indication:Ovarian Cancer,Platinum-resistant O...,Carcinosarcoma of th..., Search all connections |
Clinical trial 2020LS001Intraperitoneal FATE FT516 and Interleukin-2 (IL-2) With Intravenous Enoblituzumab in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Organization:Masonic Cancer Cente...,Product:IP FT516,Indication:Ovarian Cancer,Fallopian Tube Adeno...,Primary Peritoneal C...,Drug:Enoblituzumab,interleukin-2, Search all connections |
Clinical trial 2023(02)Efficacy and Safety of Huaier Granule in Combination With Nilaparil in First-line Maintenance Therapy in Postoperative Patients With Stage III/IV BRCA Wild-type Ovarian Cancer: a Single-center Prospective, Single-arm Study |
Clinical trial 2023-02-3121The Efficacy and Safety of The Fuzuloparib Combination With Bevacizumab in Maintenance Treatment for Platinum-Sensitive Recurrent Ovarian Cancer |
Clinical trial NCC2023-0100Phase III Randomized Trial of HIPEC in Primary Stage Three & Four Ovarian Cancer After Interval Cytoreductive Surgery (FOCUS) |
Clinical trial 2024 No. 047Sorafenib Combined With Carboplatin/Paclitaxel and Sorafenib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian Cancer: a Single-arm, Multicenter, Exploratory Clinical Study |
Clinical trial GYN-064A Phase I/II Trial of Weekly Paclitaxel In Combination With Ganetespib In Patients With Recurrent, Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer Organization:Fox Chase Cancer Cen...,Drug:paclitaxel,Indication:Recurrent Fallopian ...,Ovarian Cancer,Recurrent Primary Pe...,Product:ganetespib, Search all connections |
Clinical trial CDR0000066562Phase II Study of Paclitaxel Plus Gemcitabine in Refractory Germ Cell Tumors Organization:Eastern Cooperative ...,Product:Gemcitabine,Indication:Ovarian Cancer,Testicular Germ Cell...,Drug:paclitaxel, Search all connections |
Clinical trial CGIZ943A12101A Phase I, Open-label, Multi-center Study to Evaluate the Safety, Tolerability, Dosimetry, and Preliminary Activity of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers Organization:Novartis Pharmaceuti...,Product:[68Ga]Ga-EVS459,[177Lu]Lu-EVS459,Indication:Ovarian Cancer,lung cancer, Search all connections |
Clinical trial 03092Randomized Pilot Trial of Oral Cyclophosphamide Versus Oral Cyclophosphamide With Celecoxib for Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer Organization:City of Hope Medical...,Drug:cyclophosphamide,Indication:Fallopian tube cance...,Peritoneal Cavity Ca...,Ovarian Cancer,Product:celecoxib, Search all connections |
Clinical trial 18-067Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study) Organization:Beth Israel Deacones...,Product:Enoxaparin,Enoxaparin + Rosuvas...,Indication:Ovarian Cancer, Search all connections |
Clinical trial SYSKY-2022-549-02Effect of Sodium Thiosulfate on Nephrotoxicity of Cisplatin Intraperitoneal Heat-perfusion Chemotherapy: a Multi-center Prospective Randomized Controlled Trial. Organization:Sun Yat-Sen Memorial...,Product:Sodium Sulfate,Indication:Ovarian Cancer,Acute Kidney Injury ...,Drug:Cisplatin, Search all connections |
Clinical trial CHUV-DO-0005-OVACURE_2017Phase I/II Study to Test the Immunogenicity, Feasibility, and Safety of Autologous PEP-DC Vaccine vs. Autologous OC-DC Vaccine Followed by PEP-DC Vaccine, in Combination With Low-dose Cyclophosphamide, in Patients With Advanced HGSOC |
Clinical trial 2021-0175Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid Tumors Organization:M.D. Anderson Cancer...,Product:ZN-c3,Indication:Tumor,Ovarian Cancer,Breast Cancer,Drug:Atezolizumab, Search all connections |
Clinical trial NCI-2024-03344A Randomized Phase 1/2 Trial Evaluating the Addition of Tolinapant to Weekly Paclitaxel With or Without Bevacizumab in Patients With Recurrent Epithelial Ovarian Cancer Organization:National Cancer Inst...,Drug:Atezolizumab,Indication:Fallopian Tube Carci...,Platinum-Refractory ...,Primary Peritoneal C..., Search all connections |
Clinical trial HCC 19-164Phase IIA Trial of Delayed Initiation of Olaparib Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer |
Clinical trial Exactis-03A Phase I Trial of the Combination of Olaparib and Navitoclax in Women With High Grade Serous Epithelial Ovarian Cancer and Triple Negative Breast Cancer Organization:Sunnybrook Health Sc...,Product:Olaparib,Navitoclax,Indication:High-grade serous ca...,Triple-Negative Brea...,Ovarian Cancer,Clinical trial arm:arm_1,Abstract:Exactis-03: A phase ..., Search all connections |
Clinical trial GEICO 105-ORetrospective Multicenter Study of Elderly Patients With Ovarian Cancer Treated With Trabectedin and PLD According to SmPC |
Clinical trial KMUHIRB-F(I)-20230075To Compare the Effects of Intraoperative Use of Intravenous Anesthetics Propofol and Inhaled Anesthetics Sevoflurane on the Prognosis of Patients Undergoing Surgery for Primary Brain, Liver, Lung, and Ovarian Cancer Tumors and the Investigation of Its Mechanism of Action Organization:Kaohsiung Medical Un...,Product:Propofol,Sevoflurane,Indication:lung cancer,Brain Tumor,Liver Cancer, Search all connections |
Clinical trial 2015-0900Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur) Organization:M.D. Anderson Cancer...,Drug:AN0025,Indication:Fallopian Tube Cance...,Ovarian Cancer,Primary Peritoneal C..., Search all connections |
Clinical trial BrUOG 354BrUOG 354: A Phase II Randomized Trial of Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas Organization:Brown University,Drug:T-VEC,Lurbinectedin,Indication:Ovarian Cancer,Fallopian tube cance...,Primary Peritoneal C..., Search all connections |
Clinical trial TNG348-C101Phase 1/2, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Antitumor Activity of TNG348 Single Agent and in Combination With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or Other HRD+ Solid Tumors Organization:Tango Therapeutics,Product:TNG348,Indication:Breast Cancer,Ovarian Cancer,Pancreatic Cancer, Search all connections |
Clinical trial SELENIUM trialSafety and Efficacy of High Dose Inorganic seLenium for Preventing Chemotherapy Induced pEripheral Neuropathy in platINUM Sensitive Recurrent Ovarian, Fallopian, Primary Peritoneal Cancer: Phase III Randomised Controlled Trial Organization:Seoul National Unive...,Product:Sodium Selenite,Indication:Peripheral neuropath...,Recurrent Ovarian Ca...,Ovarian Cancer,Drug:Varlilumab, Search all connections |
Clinical trial I154A Phase I Study of a Second Generation Clusterin Antisense Oligonucleotide (OGX-011) in Combination With Docetaxel Organization:NCIC Clinical Trials...,Product:Custirsen,Indication:Bladder Cancer,Breast Cancer,Renal Cell Carcinoma, Search all connections |
Clinical trial GENEXOL PMAn Observational Study to Evaluate the Safety of the Combination Therapy of Genexol PM and Carboplatin as First-line Therapy for Ovarian Cancer Patients |
Clinical trial NEODOCInduction of Neo-Antigen Specific Cytotoxic T Cells by Autologous Tumor Lysate-loaded Specialized Cross-Presenting Dendritic Cells in Epithelial Ovarian Cancer Patients Treated With Neoadjuvant Chemotherapy, the NEODOC Study |
Clinical trial GINECO-OV127bA Multicentre Feasibility Randomized Study of Anti-PD-L1 Durvalumab (MEDI4736) With or Without Anti-CTLA-4 Tremelimumab in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Adenocarcinoma, Treated With a First-line Neo-adjuvant Strategy Organization:Arcagy Gineco Group,Product:ARM A Durvalumab/che...,ARM B Durvalumab + T...,Indication:Ovarian Cancer,Abstract:Phase Ib INEOV neoad...,Immune features of o..., Search all connections |
Clinical trial R20-100Neuroinflammation and Age-associated Brain Pathology: Two Potential Mechanisms of Cognitive Impairment in Ovarian Cancer |
Clinical trial ACROPOLI (SOLTI-1904)Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors Defined by a Single and Pre-specified Cutoff Organization:SOLTI Breast Cancer ...,Drug:Spartalizumab,Indication:MSI-H Colorectal Can...,Melanoma,Anal Cancer, Search all connections |
Clinical trial 2210263-1The Utility of Circulating Tumor DNA in Monitoring the Response to Pegylated Liposomal Doxorubicin in Platinum-resistant Ovarian Cancer |
Clinical trial GINECO-OV231A Randomized Phase II Study of Pazopanib and Weekly Paclitaxel in Patients With Platinum Resistant/Refractory Ovarian Cancer Who Relapse During Bevacizumab Maintenance |
Clinical trial 19-814A Phase 2 Study of Zafirlukast for the Treatment of Tumor-marker Only Relapsed Ovarian Cancer |
Clinical trial ZS205The IIT Study of Evaluation of Platelet-coupled IL-2 Cell Injection (P-IL-2) Single Agent and With Anti-PD-1 Monoclonal Antibody on the Safety, Tolerance and Preliminary Effectiveness in Patients With Advanced Malignant Solid Tumors Organization:Zhejiang University,Product:P-IL-2,P-IL-2 plus Anti-PD-...,Indication:Esophageal Cancer,Bladder Cancer,Liver Cancer, Search all connections |
Clinical trial 2022-LCYJ-YY01A Phase II Prospective Single-arm Clinical Study of Aribulin Combined With Carboplatin and Bevacizumab in the First-line Treatment of Platinum-sensitive Recurrent Ovarian Cancer |
Clinical trial NCI-2020-08370Phase 1 Trial of Gemcitabine Combined With the Elimusertib (BAY 1895344) ATR Inhibitor With Expansion Cohorts in Advanced Pancreatic and Ovarian Cancer Organization:National Cancer Inst...,Product:Elimusertib,Indication:Fallopian Tube Carci...,Malignant Neoplasm,Ovarian Cancer, Search all connections |
Clinical trial NCI-2011-02516A GCIG Intergroup Multicenter Phase III Trial of Open Label Carboplatin and Paclitaxel +/- NCI-Supplied Agent: Bevacizumab (NSC #704865) Compared With Oxaliplatin and Capecitabine +/- Bevacizumab as First Line Chemotherapy in Patients With Mucinous Epithelial Ovarian or Fallopian Tube Cancer (MEOC) Organization:National Cancer Inst...,Drug:Atezolizumab,Indication:Borderline Ovarian M...,Ovarian Mucinous Cys...,Recurrent Fallopian ..., Search all connections |
Product AB598 |
Clinical trial 2024 No. 050Safety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer: A Single-arm, Single-center, Exploratory Clinical Study |
Clinical trial ARC-25A Phase 1/1b Study to Evaluate the Safety and Tolerability of AB598 Monotherapy and Combination Therapy in Participants With Advanced Malignancies Organization:Arcus Biosciences,Product:AB598,Indication:Advanced Cancer,Advanced Malignancie...,Bladder Cancer, Search all connections |
Clinical trial A6334536Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations Independent of HER2 Expression With Progression After Previous Treatment Organization:Lynkcell Europe,Product:Axitinib,Indication:Breast Cancer,Ovarian Cancer,Breast Neoplasms, Search all connections |
Clinical trial MYCA (GINECO-OV220)Phase Ib / II Trial Evaluating the Association Myocet ® - Carboplatine in Patients Having a Cancer of the Ovary in Relapse, Sensitive to the Platinum |
Clinical trial 2014-0640Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies Organization:M.D. Anderson Cancer...,Drug:UTD1,Indication:Malignant Neoplasm,Clinical Stage III C...,Stage IV Cutaneous M..., Search all connections |
Clinical trial GINECO-OV119Randomized Double Blind Placebo-controlled Phase II Trial of Vargatef® (Nintedanib) in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Adenocarcinoma of the Ovary, the Fallopian Tube or Serous Adenocarcinoma of the Peritoneum Organization:Arcagy Gineco Group,Product:vargatef,Indication:Ovarian Cancer,Drug:placebo,Abstract:Targeting the CD47/T...,Consistent data abou...,CD47 expression in o..., Search all connections |
Clinical trial MCC-20-GYN-08A Phase 1 Dose Escalation of ArtemiCoffee in Patients With Advanced Ovarian Cancer |
Product BG-68501 |
Clinical trial BG-68501-101A Phase 1a/1b Study of BG-68501, a Selective CDK2 Inhibitor, in Participants With Advanced Solid Tumors Organization:BeiGene,Product:BG-68501,Indication:Breast Cancer,Small Cell Lung Canc...,Ovarian Cancer, Search all connections |
Clinical trial AGO-OVAR OP.7/TRUSTTrial on Radical Upfront Surgery in Advanced Ovarian Cancer |
Clinical trial OCTO_062Randomised Phase II Trial of Olaparib, Chemotherapy or Olaparib and Cediranib in Patients With Platinum-resistant Ovarian Cancer Organization:University of Oxford,Product:Olaparib,Cediranib,Indication:Ovarian Cancer,Drug:Tiragolumab, Search all connections |
Clinical trial 2022-0395Early Assessment of Ovarian Cancer Aggressiveness by Metabolic Imaging |
Clinical trial CUSP06-1001A Phase 1, First-in-Human Study of CUSP06, a Cadherin-6 (CDH6)-Directed Antibody-Drug Conjugate, in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors |
Clinical trial J1708Phase I Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer Organization:Sidney Kimmel Compre...,Product:Fostamatinib + Pacli...,Indication:Ovarian Cancer,Abstract:A phase 1 study of t..., Search all connections |
Clinical trial EPOC1903A Pilot Study to Evaluate the Efficacy and Safety of Preoperative Olaparib Monotherapy and Preoperative Olaparib Plus Pembrolizumab Combination Therapy in Patients With HRD-Positive Stage III or IV Advanced Epithelial Ovarian/Fallopian Tube/Primary Peritoneal Cancer Organization:National Cancer Cent...,Product:Olaparib,Indication:Ovarian Cancer,Drug:mFOLFOX6,Abstract:Neoadjuvant combinat..., Search all connections |
Clinical trial 202201907A0Next Generation Precision Imaging for Cancer Immunotherapy: Dynamic Nuclear Polarization and Metabolomics Study Organization:Chang Gung Memorial ...,Product:Hyperpolarized 13C-P...,Indication:Gynecologic Cancer,Cervical Cancer,Endometrial Cancer, Search all connections |
Clinical trial 111113-ETriweekly Chemotherapy With Bevacizumab Versus Intraperitoneal Chemotherapy as Frontline Therapy in Advanced Ovarian Cancer Organization:Far Eastern Memorial...,Drug:Cisplatin,Indication:Intraperitoneal Chem...,Bevacizumab,Ovarian Cancer, Search all connections |
Clinical trial ENGOT-OV56/NSGO-CTU-DOVACCA Randomized Clinical Trial Investigating Olaparib, Durvalumab (MEDI4736) and UV1 as Maintenance Therapy in BRCAwt Patients With Recurrent Ovarian Cancer |
Clinical trial 2021-0176Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors Organization:M.D. Anderson Cancer...,Product:LVGN3616,Indication:Metastatic Esophagea...,Stomach Cancer,Metastatic Head and ..., Search all connections |
Clinical trial M17OVHPhase III Randomized Clinical Trial for Stage III Epithelial Ovarian Cancer Randomizing Between Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy |
Clinical trial SGOV01Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study Organization:Cantonal Hospital of...,Drug:Cisplatin,Indication:Ovarian Cancer,fallopian tube carci..., Search all connections |
Clinical trial GINECO-OV235A Randomized, Open-label, Comparative, Multicenter, Phase II Study of the Efficacy and Safety of REGorafenib Versus Tamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progression |
Clinical trial ZhaoPengEarly-stage Clinical Study of Mesothelin-specific Chimericantigen Receptor T Cells (LD013) in Subjects With Refractory or Relapsed Mesothelin -Positive Ovarian Cancer |
Clinical trial NCI-2015-00054Molecular Analysis for Therapy Choice (MATCH) Organization:National Cancer Inst...,Drug:Adavosertib,Indication:Lymphoma,Malignant Neoplasm,Bladder Cancer, Search all connections |
Clinical trial MC1361A Pilot Study of the Safety and Immunogenicity of Folate Receptor Alpha Peptide-Loaded Dendritic Cell Vaccination in Patients With Advanced Stage Epithelial Ovarian Cancer Organization:Mayo Clinic,Product:Multi-epitope Folate...,Indication:Ovarian Clear Cell A...,Endometrioid Tumor,Fallopian Tube Mucin..., Search all connections |
Clinical trial BEV-DOSEA Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer - a Pragmatic Trial Organization:British Columbia Can...,Drug:Atezolizumab,Indication:Ovarian Cancer,Platinum-resistant O..., Search all connections |
Clinical trial SAHoWMU-CR2024-07-107Application of MRD Combined With Personalized Vaccine in the Adjuvant Treatment of Postoperative Recurrence Prevention of Epithelial Ovarian Cancer |
Clinical trial CDR0000068107Pilot Trial of Humanized 3S193 Monoclonal Antibody (hu3S193) in Presurgical Patients With Ovarian Cancer |
Clinical trial PRO1184-001Phase 1/2 Study of PRO1184 in Patients With Locally Advanced and/or Metastatic Solid Tumors Organization:ProfoundBio,Product:PRO1184,Indication:Ovarian Cancer,Primary Peritoneal C...,Fallopian tube cance..., Search all connections |
Clinical trial HCC 21-091Phase ll Study of a BET Inhibitor, ZEN003694, Combined With a PARP Inhibitor, Talazoparib, in Patients With Recurrent Ovarian Cancer Organization:Haider Mahdi,Drug:ZEN003694,Indication:Ovarian Cancer,Peritoneal Cancer,Fallopian tube cance...,Product:Talazoparib, Search all connections |
Clinical trial NCI-2013-02483A Pilot Study of the Immunological Effects of Neo-Adjuvant INCB024360 in Patients With Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma Organization:National Cancer Inst...,Product:Epacadostat,Indication:Fallopian Tube Cance...,Ovarian Cancer,Primary Peritoneal C..., Search all connections |
Clinical trial 2022-0231Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer Organization:M.D. Anderson Cancer...,Drug:Tiragolumab,Atezolizumab,Lurbinectedin,Indication:Ovarian Cancer, Search all connections |
Clinical trial IRB13-1235A Randomized Placebo Controlled Phase II Trial of Metformin in Conjunction With Chemotherapy Followed by Metformin Maintenance Therapy in Advanced Stage Ovarian, Fallopian Tube and Primary Peritoneal Cancer Organization:University of Chicag...,Product:Metformin,Indication:Brenner Tumor,Malignant Ascites,Malignant Pleural Ef..., Search all connections |
Clinical trial 16800Optimal Dosing of Oral Anticancer Drugs in Older Adults With Cancer: a Randomized Pilot Study. Organization:University Medical C...,Product:Olaparib,Lenvatinib,Indication:Renal Cell Carcinoma,Ovarian Cancer,Thyroid Cancer, Search all connections |
Clinical trial ZCARNK-017Phase I Trial to Evaluate Safety and Preliminary Efficacy of CLDN6/GPC3/Mesothelin/AXL-CAR-NK in Patients With CLDN6/GPC3/Mesothelin/AXL-positive Advanced Solid Tumors Organization:Second Affiliated Ho...,Product:Claudin6, GPC3, Meso...,Indication:Ovarian Cancer,Testicular Cancer,Refractory, Search all connections |
Clinical trial 21850Pilot Evaluation of Focused Ultrasound Ablation and Focused Ultrasound Ablation Plus PD-1 Antibody Blockade in Advanced Solid Tumors Organization:Craig L Slingluff Jr,Product:Poly ICLC,Indication:Melanoma,Breast Cancer,Merkel Cell Carcinom..., Search all connections |
Clinical trial M10MKO / MK1775-009Phase II Pharmacological Study With Wee-1 Inhibitor MK-1775 Combined With Carboplatin in Patients With p53 Mutated Epithelial Ovarian Cancer and Early Relapse (< 3 Months) or Progression During Standard First Line Treatment With an Additional Safety and Preliminary Anti-tumor Activity Cohort of Wee-1 Inhibitor AZD1775 Combined With Carboplatin in Patients With Platinum Resistant TP53 Mutated Epithelial Ovarian Cancer |
Clinical trial 10001662A Phase Ib Clinical Trial to Evaluate the Administration of Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer Organization:National Cancer Inst...,Drug:interleukin-2,Indication:Metastatic Solid Can...,Colorectal Cancer,Breast Cancer, Search all connections |
Clinical trial 2019-0149Randomized Phase I/II Study of AVB-S6-500 in Combination With Durvalumab (MEDI4736) in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer Organization:M.D. Anderson Cancer...,Product:Batiraxcept,Indication:Platinum-Resistant F...,Platinum-Resistant O...,Platinum-Resistant P..., Search all connections |
Clinical trial BEACONBEACON - A Phase II Study of Bevacizumab, Atezolizumab and Cobimetinib in Patients With Recurrent Platinum Resistant High Grade Serous Ovarian Cancer Organization:Peter MacCallum Canc...,Drug:Atezolizumab,Indication:Ovarian Cancer,Fallopian tube cance...,Primary Peritoneal C...,Product:Cobimetinib,Clinical trial arm:arm_1,Abstract:Beacon: A phase II s..., Search all connections |
Clinical trial GOTIC-001/JGOG3019A Randomized Phase II/III Trial of Intravenous (IV) Paclitaxel Weekly Plus IV Carboplatin Once Every 3 Weeks Versus IV Paclitaxel Weekly Plus Intraperitoneal (IP) Carboplatin Once Every 3 Weeks in Women With Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer Organization:Gynecologic Oncology...,Product:Paclitaxel + Carbopl...,Indication:Ovarian Cancer,Fallopian tube cance...,Primary Peritoneal C...,Abstract:Analyses of tumor mi..., Search all connections |
Clinical trial CRUKD/21/004- Treatment Arm 5DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial): An Umbrella-Basket Platform Trial to Evaluate the Efficacy of Targeted Therapies in Rare Adult, Paediatric and Teenage/Young Adult (TYA) Cancers With Actionable Genomic Alterations, Including Common Cancers With Rare Actionable Alterations Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. Organization:Cancer Research UK,Product:Vemurafenib,Indication:Solid Tumor,Haematological Malig...,Melanoma, Search all connections |
Clinical trial 2014-0662Matched Paired Pharmacodynamics and Feasibility Study of Pembrolizumab in Combination With Chemotherapy in Frontline Ovarian Cancer Organization:M.D. Anderson Cancer...,Drug:AN0025,Indication:Fallopian Tube Cance...,Ovarian Cancer,Primary Peritoneal C..., Search all connections |
Product Combined PIPAC / IV chemotherapy treatmentIndication:Ovarian Cancer,Peritoneal Carcinoma...,Stage III Ovarian Ca...,Clinical trial:69HCL20_0920, Search all connections |
Clinical trial 2022-0687Phase I/II Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer Organization:M.D. Anderson Cancer...,Product:TROP2-CAR-NK,Indication:Pancreatic Cancer,Ovarian Cancer,Adenocarcinoma,Drug:cyclophosphamide,fludarabine,Abstract:Phase I/II study of ..., Search all connections |
Clinical trial 69HCL20_0920Phase I Dose Escalation Study Evaluating the Safety of Adding Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) With Cisplatin-doxorubicin to the Systemic Chemotherapy, and the Recommended Phase II Dose, in Women With Insufficient Response to Carboplatin-paclitaxel for Advanced Epithelial Cancer of the Ovary, Fallopian Tubes or Peritoneum Organization:Hospices Civils de L...,Product:Combined PIPAC / IV ...,Indication:Ovarian Cancer,Peritoneal Carcinoma...,Stage III Ovarian Ca..., Search all connections |
Clinical trial S65525Visualisation of Indocyanine Green in Primary and Interval Debulking for Ovarian Cancer |
Clinical trial The TABANETOC-trialThe Effect of Tinzaparin on Biomarkers in FIGO Stage III-IV Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy - A Randomized Pilot Study |
Clinical trial OV21A Phase II Study of Intraperitoneal (IP) Plus Intravenous (IV) Chemotherapy Versus IV Carboplatin Plus Paclitaxel in Patients With Epithelial Ovarian Cancer Optimally Debulked at Surgery Following Neoadjuvant Intravenous Chemotherapy Organization:Canadian Cancer Tria...,Drug:carboplatin,paclitaxel,Indication:Fallopian tube cance...,Metastatic Cancer,Ovarian Cancer,Product:cisplatin, Search all connections |
Clinical trial 23-1455.ccA Phase 1b Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence in Patients Diagnosed With Early-stage Breast Cancer and Ovarian Cancer in Remission |
Clinical trial MITO-8Liposomal Doxorubicin Versus Carboplatin/Paclitaxel in Patients With Ovarian Cancer Recurrence Between 6 and 12 Months After Previous Platinum Based Therapy: Phase III Randomized Multicenter Study Amendment Title Protocol Version 2.0: Phase III International Multicenter Randomized Study Testing the Effect on Survival of Prolonging Platinum-free Interval in Patients With Ovarian Cancer Recurring Between 6 and 12 Months After Previous Platinum Based Chemotherapy. Organization:National Cancer Inst...,Product:Stealth Liposomal Do...,Topotecan,Indication:Ovarian Cancer,Drug:carboplatin,paclitaxel,Gemcitabine, Search all connections |
Clinical trial 12-275A Phase II Randomized Study: Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer |
Clinical trial NCI-2021-00615A Randomized Phase II Trial of Triplet Therapy (A PD-L1 Inhibitor Durvalumab (MEDI4736) in Combination With Olaparib and Cediranib) Compared to Olaparib and Cediranib or Durvalumab (MEDI4736) and Cediranib or Standard of Care Chemotherapy in Women With Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Primary Peritoneal or Fallopian Cancer Who Have Received Prior Bevacizumab |
Clinical trial AP10CP01A Phase 1/2 Study to Assess the Safety and Antitumor Activity of APL-5125 in Adults With Selected Advanced Solid Tumors Organization:Apollo Therapeutics,Product:APL-5125,Indication:Colorectal Cancer,Cholangiocarcinoma,Appendix Adenocarcin..., Search all connections |
Clinical trial CRUKD/21/004- Treatment Arm 4DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial): An Umbrella-Basket Platform Trial to Evaluate the Efficacy of Targeted Therapies in Rare Adult, Paediatric and Teenage/Young Adult (TYA) Cancers With Actionable Genomic Alterations, Including Common Cancers With Rare Actionable Alterations. Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Teenage/Young Adult and Paediatric Patients With Cancers With HER2 Amplification or Activating Mutations. Organization:Cancer Research UK,Drug:Trastuzumab,Indication:Solid Tumor,Haematological Malig...,Colorectal Cancer, Search all connections |
Clinical trial OSU-09138Phase I Active Immunotherapy Trial With a Combination of Two Chimeric (Trastuzumab-like and Pertuzumab-like)Human Epidermal Growth Factor Receptor 2 (HER-2) B Cell Peptide Vaccine Emulsified in ISA 720 and Nor-MDP Adjuvant in Patients With Advanced Solid Tumors Organization:Robert Wesolowski,Product:HER-2 vaccine,Extension HER-2 vacc...,Indication:Malignant Solid Tumo...,Breast Cancer,Colorectal Cancer, Search all connections |
Clinical trial 56UCS2017EXemestane in Progesterone and/or Estrogen Receptor Positive Epithelial Ovarian Cancer: A Randomized Phase III Trial, EXPERT |
Clinical trial PITHACPhase I Clinical Trial Testing the Dose Escalation and Expansion of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration for the Management of Pleural Carcinosis Organization:Dr Jean Yannis Peren...,Product:Cisplatine Teva,Indication:Mesothelioma,malignant,cancer, Search all connections |
Clinical trial 0752-20-HMOA Phase I/II Dose Escalation, Safety and Efficacy Study of Anti-NY-ESO-1 T Cell Receptor (TCR)-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers Organization:Hadassah Medical Org...,Product:Cyclophosphamide,Indication:Sarcoma,Synovial,Soft Tissue Sarcoma, Search all connections |
Clinical trial UCDCC307A Randomized Trial of Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy Organization:Eve Rodler,Product:Tart Cherry Juice,Indication:Breast Cancer,Breast Cancer Stage ...,Breast Cancer Stage ..., Search all connections |
Product rF-NY-ESO-1 vaccineIndication:Fallopian tube cance...,Ovarian Cancer,Peritoneal Cavity Ca...,Clinical trial:LUD 2002-012, Search all connections |
Product rV-NY-ESO-1Indication:Fallopian tube cance...,Ovarian Cancer,Peritoneal Cavity Ca...,Clinical trial:LUD 2002-012, Search all connections |
Clinical trial LUD 2002-012Phase II Study of Recombinant Vaccinia-NY-ESO-1 (rV-NY-ESO-1) and Recombinant Fowlpox-NY-ESO-1 (rF-NY-ESO-1) in Patients With Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma Whose Tumors Express NY-ESO-1 or LAGE-1 Antigen Organization:Ludwig Institute for...,Product:rV-NY-ESO-1,rF-NY-ESO-1 vaccine,Indication:Fallopian tube cance...,Ovarian Cancer,Peritoneal Cavity Ca..., Search all connections |
Clinical trial NCI-2014-01107Phase I Study of MLN0128 (TAK-228) (NSC# 768435) in Combination With Ziv-Aflibercept (NSC# 724770) in Patients With Advanced Cancers Organization:National Cancer Inst...,Product:Sapanisertib,Indication:Malignant Neoplasm,Fibrolamellar Carcin...,Metastatic Malignant..., Search all connections |
Clinical trial NCCH1905Asian Multicenter Prospective Study of Circulating Tumor DNA Sequencing: A-TRAIN Organization:National Cancer Cent...,Product:NGS analysis of ctDN...,Indication:Cervical Cancer,Ovarian Clear Cell C...,Nasopharyngeal Carci..., Search all connections |
Clinical trial NX-1607-101A Phase 1a, Dose Escalation, Safety and Tolerability Study of NX-1607, a Casitas B-lineage Lymphoma Proto-oncogene (CBL-B) Inhibitor, in Adults With Advanced Malignancies, With Phase 1b Expansion in Select Tumor Types Organization:Nurix Therapeutics,Product:NX-1607,Indication:Ovarian Cancer,Epithelial,Stomach Cancer, Search all connections |
Clinical trial 10000237Phase II Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer Organization:National Cancer Inst...,Drug:Tiragolumab,Indication:Gynecologic Cancer,Gynecologic Neoplasm...,Peritoneal Carcinoma..., Search all connections |
Clinical trial 23-OBU-FJ-OC-II-003A Single-arm, Exploratory Study of Adebrelimab Combined With Fuzuloparib in the Treatment of Patients With Recurrent Platinum-resistant Ovarian Cancer Organization:Fujian Cancer Hospit...,Drug:Anlotinib,Indication:Ovarian Cancer,Ovarian Diseases,Product:Fuzuloparib, Search all connections |
Clinical trial 136618A Multicentre Phase II Randomised Controlled Trial to Evaluate the Efficacy of Adaptive Therapy (AT) With Carboplatin, Based on Changes in CA125, in Patients With Relapsed Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer Organization:University College L...,Drug:AN0025,Indication:Ovarian Cancer,Relapsed Ovarian Can...,Fallopian tube cance..., Search all connections |
Clinical trial 150150A Phase I/II Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor in Small Cell Cancers Organization:National Cancer Inst...,Product:Topotecan,Indication:cancer,Non-Small Cell Lung,Ovarian Cancer, Search all connections |
Clinical trial 2019-001982-34Syöpäpotilaan Ennusteen Parantaminen Muuttamalla syövän mikroympäristöä ja Metaboliaa Liikunnalla ja lääkkeellisesti - Measuring Oncological Value of Exercise and Statin Organization:Tampere University H...,Drug:Atorvastatin,Indication:Prostate Cancer,Breast Cancer,Renal Cell Carcinoma, Search all connections |
Clinical trial NCI-2020-05956Pilot Trial of Nivolumab Plus Cabozantinib for Advanced Solid Tumors in Patients With HIV Infection Organization:National Cancer Inst...,Product:Cabozantinib,Indication:Thyroid Carcinoma,Head and Neck Carcin...,Hepatocellular Carci..., Search all connections |
Clinical trial S2022-2461The Real World Efficacy and Safety of Niraparib in Korean Women With Primary and Recurrent Epithelial Ovarian Cancer |
Clinical trial IIT2020-03-Rimel-STOVStatin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer |
Product NY-ESO-1 Peptide vaccineIndication:Stage IV Ovarian Can...,Ovarian Cancer,Ovarian Cancer Stage...,Clinical trial:STUDY00005324, Search all connections |
Clinical trial STUDY00005324A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients Organization:Georgetown Universit...,Product:NY-ESO-1 Peptide vac...,Indication:Stage IV Ovarian Can...,Ovarian Cancer,Ovarian Cancer Stage...,Drug:T-VEC, Search all connections |
Clinical trial 05-122Phase II Study of Intrathecal I-3F8 in Patients With GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms |
Clinical trial CCR3808A Phase I Trial of VS-6766 (RO5126766) (a Dual RAF/MEK Inhibitor) Exploring Intermittent, Oral Dosing Regimens in Patients With Solid Tumours or Multiple Myeloma, With an Expansion to Explore Intermittent Dosing in Combination With Everolimus Organization:Royal Marsden NHS Fo...,Drug:Avutometinib,Indication:Solid Tumours,Multiple Myeloma,lung cancer,Product:Everolimus, Search all connections |
Clinical trial EU CT nr: 2023-505938-98-00[68Ga]Ga-FAPI-46 PET/CT: The Diagnostic Accuracy for Primary Staging and Re-staging of Patients With Ovarian Cancer |
Clinical trial SUROVAAn International Retrospective Observational Study Comparing Primary Cytoreductive Surgery With Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery in Patients With Carcinoma of the Ovary, Fallopian Tubes and Peritoneum Organization:Clinica Universidad ...,Product:Neoadjuvant chemothe...,Adjuvant chemotherap...,Indication:Ovarian Cancer,Fallopian Tube Neopl...,Peritoneal Neoplasms, Search all connections |
Clinical trial NCI-2015-00051A Phase 2 Study of Olaparib and Cediranib for the Treatment of Recurrent Ovarian Cancer Organization:National Cancer Inst...,Product:Cediranib,Indication:fallopian tube carci...,Endometrioid Adenoca...,Ovarian Serous Adeno..., Search all connections |
Clinical trial IRB-300003336A Phase II Study in Newly Diagnosed Stage III/IV Epithelial Ovarian Cancer Evaluating Carbo/Taxol/Pembro in Patients Receiving Neoadjuvant Chemotherapy (NACT) Followed by Olaparib/Pembro Maintenance |
Clinical trial EORTC-55092Phase IB-II, Open Label, Multicenter Feasibility Study of Pazopanib in Combination With Paclitaxel and Carboplatin in Patients With Platinum-Refractory/Resistant Ovarian, Fallopian Tube or Peritoneal Carcinoma Organization:European Organisatio...,Drug:carboplatin,paclitaxel,Indication:Fallopian tube cance...,Ovarian Cancer,Primary Peritoneal C...,Product:Pazopanib, Search all connections |
Clinical trial WJW-2-PEG-OCThe Efficacy and Safety of Secondary Prophylaxis Versus ANC< 1000/mm3 Administration of PEG-rhG-CSF in Patients Receiving Cytotoxic Chemotherapy for Gynecologic Malignancies |
Clinical trial NCI-2016-01081A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin, CTEP-Supplied Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin and CTEP-Supplied Bevacizumab in Platinum Resistant Ovarian Cancer Organization:National Cancer Inst...,Drug:Atezolizumab,Indication:Fallopian Tube High ...,Ovarian High Grade S...,Ovarian Seromucinous..., Search all connections |
Clinical trial MCC-18-14152A Phase 1/1b Clinical Trial of Niraparib and Neratinib in Advanced Solid Tumors With an Expansion Cohort in Platinum-resistant Ovarian Cancer Organization:Virginia Commonwealt...,Product:Neratinib,Niraparib,Indication:Advanced Solid Tumor,Ovarian Cancer, Search all connections |
Clinical trial i 287616A Phase I, Open Label Study Evaluating the Safety and Efficacy of Adoptive Transfer of Autologous NY-ESO-1 CD8-TCR Engineered T Cells and NY-ESO-1 CD4-TCR Engineered Hematopoietic Stem Cells (HSC) After a Myeloablative Conditioning Regimen, With Administration of IL-2 in Patients With Recurrent or Treatment Refractory Ovarian, Fallopian Tube or Primary Peritoneal Cancer Organization:Roswell Park Cancer ...,Product:Aldesleukin,Indication:Platinum-Resistant F...,Platinum-Resistant O...,Platinum-Resistant P..., Search all connections |
Clinical trial SCRI REFMAL 314Phase Ib Dose-Escalation Study of LCL161 in Combination With Oral Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer (SCLC) and Select Gynecologic Malignancies Organization:SCRI Development Inn...,Product:LCL161,Topotecan,Pegylated GCSF,Indication:Small Cell Lung Canc...,Ovarian Cancer, Search all connections |
Clinical trial 4-2023-0794A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV07/ ENGOT-ov80 Study) Organization:Yonsei University,Product:Dostarlimab,Indication:Ovarian Cancer,Endometrial Neoplasm...,Cervical Cancer, Search all connections |
Clinical trial 2017-0264Phase Ib Clinical Investigation of Intraperitoneal Ipilimumab and Nivolumab in Patients With Peritoneal Carcinomatosis Due to Gynecologic Cancers Indication:Stage IVB Uterine Co...,Peritoneal Neoplasm,Malignant Retroperit...,Drug:T-VEC,Organization:M.D. Anderson Cancer..., Search all connections |
Product NKG2D CAR-NKIndication:Metastatic Colorecta...,Ovarian Cancer,acute myeloid leukem...,Clinical trial:CARNK-002,IRB-2022-674,[2023]TXB--001, Search all connections |
Clinical trial OZM-058A Phase II, Open-Label, Randomized, Multi-Centre Study, of Neoadjuvant Olaparib in Patients With Platinum Sensitive Recurrent High Grade Serous Ovarian/Primary Peritoneal or Fallopian Tube Cancer Organization:University Health Ne...,Product:Olaparib,Platinum-based Chemo...,Indication:Ovarian Cancer,Fallopian tube cance...,Neoadjuvant Treatmen...,Abstract:Phase II randomized ..., Search all connections |
Clinical trial STUDY00020679Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) Trial: Adaptive Clinical Treatment (ACT) |
Clinical trial 6414Development and Validation of a Risk Prediction Model for Venous Thromboembolism in Gynecological Cancer Patients Undergoing Systemic Antineoplastic Treatment: The Gynecological Cancer Associated Thrombosis (GynCAT) Study Organization:Fondazione Policlini...,Product:Anticoagulant,Indication:Cancer-associated Th...,Venous Thromboemboli...,Gynecologic Cancer, Search all connections |
Clinical trial 201-17-201A Phase I/II Study Evaluating the Dosing, Safety, Efficacy, and Biological Activity of Intraperitoneal IMNN-001 (IL-12 Plasmid Formulated With PEG-PEI-Cholesterol Lipopolymer) Administered in Combination With Neoadjuvant Chemotherapy (NACT) in Patients Newly Diagnosed With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer Organization:Imunon,Drug:IMNN-001,AN0025,Tiragolumab,Indication:Ovarian Cancer,Fallopian tube cance...,Primary Peritoneal C..., Search all connections |
Clinical trial GINECO-OV239BLongitudinal Study Evaluating in Real Life the Tolerability of Niraparib in Maintenance After Platine-based Chemotherapy for Patients With Ovarian Cancer Late Relapse : the French GINECO - NiQoLe Study Organization:Arcagy Gineco Group,Product:Niraparib,Indication:Ovarian Cancer,Abstract:Toxicity profile and..., Search all connections |
Clinical trial XB002-101A Dose-Escalation and Expansion Study of the Safety and Pharmacokinetics of XB002 as Single-Agent and Combination Therapy in Subjects With Inoperable Locally Advanced or Metastatic Solid Tumors |
Clinical trial HCC 22-066A Non-randomized Prospective Phase II Study of Upfront Maintenance Olaparib in Advanced Ovarian Cancer BRCAwt Patients With Known Homologous Recombination Deficiency |
Clinical trial ChenJian2The Correlation Between Homologous Recombination Deficiency Detection and the Efficacy of PARP Inhibitors in Ovarian Cancer |
Clinical trial ESR-20-21103Non-Randomized, Open-Label, Prospective Phase II Trial to Better Characterize the Status of HRD Leading to a Benefit From Olaparib in Combination With Bevacizumab in Patients With Advanced FIGO Stage III-IV High Grade Serous or Endometrioid Ovarian, Fallopian Tube, or Peritoneal Cancer After Standard First-Line Treatment |
Clinical trial ENGOT-OV30 / NSGONSGO-OV-UMB1; ENGOT-OV30 / NSGO: A Phase II Umbrella Trial in Patients With Relapsed Ovarian Cancer |
Clinical trial NOGGO-ov44Phase II Investigational Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer Organization:North Eastern German...,Product:Pembrolizumab,Indication:Ovarian Cancer,Low-grade serous car...,Primary Peritoneal C...,Abstract:First results of the..., Search all connections |
Clinical trial 2015-0519A Pilot Study of Wee1 Inhibition Induction Prior to Tumor Reductive Surgery in Ovarian Cancer Organization:M.D. Anderson Cancer...,Drug:Adavosertib,Indication:Fallopian Tube Carci...,Ovarian Cancer,Advanced Primary Per..., Search all connections |
Clinical trial CDR0000318803A Phase I Study Of NY-ESO-1b Peptide Plus Montanide ® ISA-51 In Patients With Ovarian, Primary Peritoneal, Or Fallopian Tube Cancer Organization:Ludwig Institute for...,Product:NY-ESO-1,Indication:Fallopian tube cance...,Ovarian Cancer,Primary Peritoneal C..., Search all connections |
Clinical trial 5397A Phase II, Single-Arm Trial Assessing Alternative Dosing Of Niraparib To Decrease Dose Interruption In First Line Maintenance Treatment For Ovarian Cancer: Dose Escalation Organization:Sunnybrook Health Sc...,Product:Niraparib,Indication:Ovarian Cancer,Stage III Ovarian Ca...,Ovarian Serous Adeno..., Search all connections |
Clinical trial UMCLATP7A Transporter as Biomarker for Predicting Chemoresistance of Serous Ovarian Cancer Organization:University Medical C...,Drug:AN0025,Indication:Gynecologic Cancer,Ovarian Cancer,High-grade serous ca..., Search all connections |
Clinical trial MCC-20-GYN-06A Phase I Dose-Escalation Study on the Safety of Lapatinib With Dose-Dense Paclitaxel in Patients With Platinum-Resistant Ovarian Cancer |
Clinical trial HCC 22-142Phase l Study of a BET Inhibitor, ZEN003694, Combined With a PARP Inhibitor, Niraparib in Patients With Metastatic or Recurrent Solid Tumors Organization:Haider Mahdi,Drug:ZEN003694,Indication:Ovarian Cancer,Recurrent Solid Tumo...,Product:Niraparib, Search all connections |
Clinical trial NCI-2020-06906A Pharmacodynamics-Driven Trial of Talazoparib, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Aberrations in Genes Involved in DNA Damage Response Organization:National Cancer Inst...,Product:Talazoparib,Indication:Pancreatic Carcinoma,Breast Cancer,Breast Cancer, Stage..., Search all connections |
Clinical trial HCC 21-166The Efficacy of T-regulatory Cell Depletion With E7777 Combined With Immune Checkpoint Inhibitor, Pembrolizumab, in Recurrent or Metastatic Solid Tumors: Phase I/II Study |
Clinical trial CIMS-2019-014FMFES Positron Emission Tomography (PET) for Detection of Newly-diagnosed ER+ Endometrial and Ovarian Cancers Organization:Centre de recherche ...,Product:Loperamide,hyoscine-n-butylbrom...,Indication:Endometrial Cancer,Ovarian Cancer, Search all connections |
Clinical trial IRB00044434A Phase II Trial Comparing Quality of Life After HIPEC in Patients With Stage IIIC and IV Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma Organization:Wake Forest Universi...,Drug:AN0025,Indication:Fallopian Tube Cance...,Ovarian Cancer,Primary Peritoneal C..., Search all connections |
Clinical trial HCC 21-249Phase I Trial of CPI-0209 in Combination With Carboplatin in Patients With Platinum Sensitive Recurrent Ovarian Cancer |
Product ALVAC-NY-ESO-1-TRICOM vaccineIndication:Fallopian tube cance...,Ovarian Cancer,Peritoneal Cavity Ca...,Clinical trial:LUD2007-005, Search all connections |
Clinical trial LUD2007-005Phase I Study of ALVAC(2)-NY-ESO-1(M)/TRICOM (VCP2292) in Patients With Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma Whose Tumors Express NY-ESO-1 or LAGE-1 Antigen Organization:Ludwig Institute for...,Product:ALVAC-NY-ESO-1-TRICO...,Indication:Fallopian tube cance...,Ovarian Cancer,Peritoneal Cavity Ca...,Drug:GM-CSF, Search all connections |
Clinical trial 100166A Phase II Study Using Short-Term Cultured, Autologous Tumor-Infiltrating Lymphocytes Following a Lymphodepleting Regimen in Metastatic Cancers Plus the Administration of Pembrolizumab Organization:National Cancer Inst...,Product:Young TIL,Aldesleukin,Indication:Colorectal Cancer,Pancreatic Cancer,Ovarian Cancer, Search all connections |
Clinical trial 20190729A Randomized Double Blind, Multicenter Trial to Assess Time-interval Between Cytoreductive Surgery and Adjuvant Chemotherapy After Administration of Local Anesthetic Intraperitoneally/Perioperatively in Advanced Epithelial Ovarian Cancer |
Clinical trial UW-19-681Niraparib Maintenance in Patients With Advanced Ovarian Cancer at Neoadjuvant Setting - a Phase 2, Single-arm Trial (NEOPRIMA Trial) |
Clinical trial 2000036114A Phase II Evaluation of Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2-SN-38 Antibody-drug Conjugate in Recurrent or Persistent Platinum-resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers |
Clinical trial CDR0000339682Single-Dose, Cohort Study of Increasing Doses of Yttrium-90 Conjugated to Humanized Monoclonal Antibody 3S193 (90Y-hu3S193) in Patients With Advanced Ovarian Cancer |
Clinical trial UMCC 2020.122A Phase 1 Dose-Escalation Trial of Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer Organization:University of Michig...,Product:Talazoparib,Belinostat,Indication:Breast Cancer,Metastatic Castratio...,Ovarian Cancer, Search all connections |
Clinical trial IRB00089583A Phase 1 Study of Palbociclib in Combination With Cisplatin or Carboplatin in Advanced Solid Malignancies Organization:Emory University,Drug:AN0025,Indication:Solid Tumor,Stage III Pancreatic...,Breast Cancer, Search all connections |
Clinical trial TILs-001-DCPhase I Study Evaluating the Feasibility and Safety of Infusion of "Re-Stimulated" Autologous TILs Followed by Low-Dose IL-2 Therapy in Patients With Platinum Resistant High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Organization:University Health Ne...,Product:Re-stimulated TILs,Indication:Recurrent,Platinum-resistant,Ovarian Cancer,Drug:IL-2, Search all connections |
Clinical trial 2021LS103MT2021-27 Intraperitoneal FT538 With Intravenous Enoblituzumab in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Organization:Masonic Cancer Cente...,Product:FT538,Indication:Cancer,Solid Tumor,Ovarian Cancer,Drug:Enoblituzumab, Search all connections |
Product ZafirlukastIndication:Allergy to Cats,Ovarian Cancer,Clinical trial:ACC001,19-814,Document:DailyMed Label: ACCO...,Organization:State of Florida DOH...,Strides Pharma Scien...,American Health Pack..., Search all connections |
Clinical trial GINECO-OV236bA Randomized, Double-blinded, Phase III Study of Atezolizumab Versus Placebo in Patients With Late Relapse of Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer Treated by Platinum-based Chemotherapy and Bevacizumab Organization:Arcagy Gineco Group,Product:Atezolizumab + Avast...,Placebo + Avastin + ...,Indication:Ovarian Cancer, Search all connections |
Clinical trial 2023LS185Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Organization:Masonic Cancer Cente...,Product:FT536,Fludarabine,Indication:Gynecologic Cancer,Ovarian Cancer,Fallopian tube cance...,Drug:cyclophosphamide, Search all connections |
Clinical trial 2000020232A Randomized Phase II Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab in Recurrent or Persistent Platinum-resistant/Refractory Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers Organization:Yale University,Product:Ixabepilone,Indication:Ovarian Cancer,Fallopian tube cance...,Primary Peritoneal C...,Drug:Atezolizumab, Search all connections |
Clinical trial MEDOPP557Phase II Study to Assess the Efficacy of Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression (The ANALLISA Study) Organization:MedSIR,Product:Niraparib,Indication:Ovarian Cancer,Oligometastatic Dise...,Ovarian Serous Tumor, Search all connections |
Clinical trial 2021-0299Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax Organization:M.D. Anderson Cancer...,Drug:Atezolizumab,Indication:Breast Carcinoma,Endometrial Cancer,Fallopian Tube Carci..., Search all connections |
Product HIPECIndication:Ovarian Neoplasms,Ovarian Cancer,Gallbladder Adenocar...,Clinical trial:CHIPPI-1808,2202522011, Search all connections |
Clinical trial CHIPPI-1808Phase III Randomized Clinical Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer Considering Two Different Settings: Primary Debulking Surgery (PDS) and Interval Debulking Surgery (IDS) |
Clinical trial 214787A Phase II Trial of Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer |
Clinical trial 2020-1241Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations Organization:M.D. Anderson Cancer...,Product:Copanlisib,Indication:Endometrial Cancer,Ovarian Cancer,Drug:fulvestrant, Search all connections |
Clinical trial BrUOG 390BrUOG 390: Neoadjuvant Treatment With Talazoparib for Women With Newly Diagnosed, Advanced Ovarian Cancer Associated With a Mutation in BRCA1 or BRCA2 (mBRCA) Organization:Brown University,Product:Talazoparib,Indication:BRCA1 Mutation,BRCA2 mutation,Ovarian Cancer, Search all connections |
Clinical trial KGOG3067A Randomized Phase II Study of Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance Organization:Korea University Gur...,Drug:cyclophosphamide,Indication:Ovarian Cancer,Drug Related Neoplas..., Search all connections |
Clinical trial INST 1420A Randomized Placebo-controlled Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients Organization:New Mexico Cancer Ca...,Product:Ketorolac,Indication:Ovarian Cancer,Fallopian tube cance...,Peritoneal Cancer, Search all connections |
Clinical trial PEPN2011A Phase 1/2 Study of Tegavivint (NSC#826393) in Children, Adolescents, and Young Adults With Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors Organization:Children's Oncology ...,Drug:Tegavivint,Indication:Colorectal cancer,Endometrial Cancer,Melanoma, Search all connections |
Clinical trial NM1F-T1-01A Phase 1 Study to Investigate the Safety, Tolerability, Pharmacokinetics/Pharmacodynamics, and Antitumor Activity of NM1F as Monotherapy and in Combination With Pembrolizumab in Subjects With Locally Advanced/Metastatic Solid Tumors Organization:Hefei TG ImmunoPharm...,Product:NM1F,Pembrolizumab,Indication:Ovarian Cancer,Melanoma,Triple-Negative Brea..., Search all connections |
Product Young TIL |
Clinical trial 6304Phase I/II Study of Combination Immunotherapy for the Generation of HER-2/Neu (HER2) Specific Cytotoxic T Cells (CTL) in Vivo Organization:University of Washin...,Product:HER-2/neu Peptide Va...,Indication:HER2/Neu Positive,HLA-A2 Positive Cell...,Breast Cancer, Search all connections |
Clinical trial AGO-OVAR 28Niraparib vs Niraparib in Combination With Bevacizumab in Patients With Carboplatinum-taxane Based Chemotherapy in Advanced Ovarian Cancer (A Multicentre Randomised Phase III Trial) Organization:AGO Study Group,Drug:AN0025,Tiragolumab,Atezolizumab,Indication:Ovarian Cancer,Fallopian tube cance...,Peritoneal Cancer,Product:Niraparib, Search all connections |
Clinical trial NCI-2021-02850Phase I/Ib Trial Evaluating the Safety and Efficacy of BET Inhibitor, ZEN003694 With PD-1 Inhibitor, Nivolumab With or Without CTLA-4 Inhibitor, Ipilimumab in Solid Tumors Organization:National Cancer Inst...,Product:ZEN-3694,Ipilimumab,Nivolumab,Indication:Metastatic Malignant...,Recurrent Malignant ...,Platinum-Resistant O..., Search all connections |
Clinical trial 20205846Phase I Dose-Escalating and Phase II Dose-Expansion Study of N-Acetyl-Cysteine (NAC) Administration to Ovarian Cancer Patients Receiving Platinum-Based Therapy (PBT) for the Mitigation of Chemotherapy-Related Cognitive Impairment (CRCI) Organization:University of Califo...,Product:N-Acetyl-Cysteine,Indication:Ovarian Cancer,Cognitive Impairment, Search all connections |
Clinical trial LOXO-RAS-20001A Phase 1/2 Study of LY3537982 in Patients With KRAS G12C-Mutant Advanced Solid Tumors Organization:Eli Lilly and Compan...,Drug:LY3537982,Indication:cancer,Non-Small Cell Lung,Colorectal Cancer, Search all connections |
Clinical trial PESCOA Phase 2 Study of Pembrolizumab (MK-3475), DPX-Survivac Vaccine and Low Dose of Cyclophosphamide Combination in Patients With Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer Organization:University Health Ne...,Product:Pembrolizumab,DPX-Survivac,Indication:Advanced Cancer,Ovarian Cancer,Primary Peritoneal C...,Drug:cyclophosphamide, Search all connections |
Clinical trial MCC-21113A Phase I Clinical Trial of an Infusion of Autologous T Cells Genetically Engineered With a Chimeric Receptor to Target the Follicle-Stimulating Hormone Receptor in Patients With Recurrent Ovarian Cancer |
Clinical trial HUS33342021Systems Oncology Approach to Optimize Ovarian Cancer Treatment |
Clinical trial CHN-PLAGH-BT-040A Phase I/II, Open-label, Two-arm, Single-center Study to Evaluate the Safety and Efficacy of the Pan-immunotherapy in Subjects With Relapsed/Refractory Ovarian Cancer Organization:Chinese PLA General ...,Product:Manganese Chloride,Platinum chemotherap...,Indication:Ovarian Cancer,Drug:Abraxane,PD-1 antibody, Search all connections |
Clinical trial i 60417A Phase I/IIa Safety and Immunologic Efficacy Trial of Intraperitoneal Induction of CTLs Combined With Alpha-Dendritic Cell Vaccine for Primary Ovarian Cancer Organization:Roswell Park Cancer ...,Product:Alpha-type-1 Polariz...,Indication:Fallopian Tube Cance...,Ovarian Cancer,Primary Peritoneal C..., Search all connections |
Clinical trial 170011Phase 1 Study of Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer Organization:National Cancer Inst...,Product:Autologous Monocytes...,Indication:Fallopian tube cance...,Ovarian Cancer,Primary Peritoneal C..., Search all connections |
Clinical trial 00-014Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients Organization:Memorial Sloan Kette...,Product:PCR/PCR/LDR Strategy,Indication:Breast Cancer,Bladder Cancer,Renal Cell Carcinoma, Search all connections |
Clinical trial IRFMN-OVA-7814A Multicenter, Open-label Phase II Trial of a New Customized Dosing (RADAR Dosing) of Niraparib as Maintenance Therapy in Platinum Sensitive Ovarian, Fallopian Tube or Primary Peritoneal Recurrent Cancer Patients Organization:Mario Negri Institut...,Product:Niraparib,Indication:Ovarian Cancer,Fallopian tube cance...,Primary Peritoneal C..., Search all connections |
Clinical trial INST 1419A Phase 1-2 Study of the Combination of Olaparib and Tremelimumab, in BRCA1 and BRCA2 Mutation Carriers With Recurrent Ovarian Cancer Organization:New Mexico Cancer Ca...,Product:Olaparib,Tremelimumab,Indication:Ovarian Cancer,Fallopian tube cance...,Peritoneal Neoplasms, Search all connections |
Clinical trial ESPS-001A Phase 1b/2a Three-Part Open-Label Multicenter Study to Evaluate the Safety and Efficacy of LY2880070 as Monotherapy and in Combination With Gemcitabine in Patients With Advanced or Metastatic Cancer Organization:Esperas Pharma,Product:LY2880070,Indication:Solid Tumors,Colorectal Cancer,Breast Cancer, Search all connections |
Clinical trial S1714A Prospective Observational Cohort Study to Develop a Predictive Model of Taxane-Induced Peripheral Neuropathy in Cancer Patients Organization:SWOG Cancer Research...,Drug:Cisplatin,Indication:Breast Cancer,Stage II Breast Canc...,Stage IIB Breast Can..., Search all connections |
Clinical trial 07-380Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With GM-CSF and Imiquimod Organization:Beth Israel Deacones...,Drug:GM-CSF,imiquimod,Indication:Ovarian Cancer,Primary Peritoneal C...,Fallopian tube cance...,Product:Dendritic Cell/Tumor..., Search all connections |
Clinical trial GINECO-OV129bRandomized Study of Paclitaxel-carboplatin Followed by Niraparib Compared to Paclitaxel-carboplatin-bevacizumab Followed by Niraparib+Bevacizumab in Patients With Advanced Ovarian Cancer, Following a Front-line Complete Surgery Organization:Arcagy Gineco Group,Drug:Cisplatin,Indication:Ovarian Cancer,Product:Bevacizumab-Awwb,Niraparib, Search all connections |
Clinical trial 16-263A Phase II Study With a Safety lead-in of Nivolumab in Combination With Bevacizumab or in Combination With Bevacizumab and Rucaparib for the Treatment of Relapsed Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer Organization:Dana-Farber Cancer I...,Drug:Atezolizumab,Indication:Peritoneal Cancer,Ovarian Cancer,Fallopian tube cance...,Product:Nivolumab,Rucaparib, Search all connections |
Clinical trial Pro00068544A Pilot Study Investigating the Effect of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers of Mullerian Origin Organization:AA Secord,Product:Pembrolizumab,Indication:Gynecologic Neoplasm...,Ovarian Cancer,Uterine Endometrial ..., Search all connections |
Clinical trial 23-493A Phase 1b Study of Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cell Therapy in Combination With N-803 (Il-15 Superagonist) in Recurrent Ovarian Cancer Organization:Dana-Farber Cancer I...,Product:Cytokine-Induced Mem...,IL-15 Superagonist,Indication:Platinum-resistant O...,Recurrent Ovarian Ca...,Ovarian Cancer, Search all connections |
Clinical trial 2022-0685Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy Organization:M.D. Anderson Cancer...,Product:Pembrolizumab,Indication:Ovarian Cancer,Drug:Atezolizumab,cyclophosphamide, Search all connections |
Clinical trial UF-STO-ETG-003Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types Organization:University of Florid...,Drug:Atezolizumab,Indication:Bile Duct Cancer,Gallbladder Cancer,Breast Cancer, Search all connections |
Clinical trial SPH-B013-201A Multicenter, Randomized, Double-blind, Parallel-controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of B013 Combined With Paclitaxel in the Treatment of Platinum-resistant Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer. Organization:Shanghai Jiaolian Dr...,Product:B013,Placebo,Indication:Ovarian Cancer,Drug:Tiragolumab, Search all connections |
Clinical trial LOXO-ENC-23001A Phase 1 Trial Investigating LY4101174, an Antibody-Drug Conjugate Targeting Nectin-4, in Participants With Recurrent, Advanced or Metastatic Solid Tumors Organization:Eli Lilly and Compan...,Product:LY4101174,Indication:Metastatic Solid Tum...,Recurrent Solid Tumo...,Advanced Solid Tumor, Search all connections |
Clinical trial 1301-02Phase Ib Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors Organization:University Health Ne...,Drug:cyclophosphamide,Indication:NY-ESO-1 Expressing ...,Synovial Sarcoma,Melanoma, Search all connections |
Product huCART-mesoIndication:Pancreatic Cancer,Ovarian Cancer,Adenocarcinoma of th...,Clinical trial:827644 (UPCC 14217), Search all connections |
Clinical trial STRO-002-GM2A Phase 1 Open-Label, Safety, Pharmacokinetic and Preliminary Efficacy Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Patients With Advanced Epithelial Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Organization:Sutro Biopharma,Product:STRO-002,Indication:Ovarian Cancer,Fallopian tube cance...,Primary Peritoneal C...,Drug:Atezolizumab,Clinical trial arm:arm_1,Dose Escalation, Search all connections |
Clinical trial P-MUC1C-ALLO1-001A Phase 1 Dose Escalation and Expanded Cohort Study of P-MUC1C-ALLO1 in Adult Subjects With Advanced or Metastatic Solid Tumors Organization:Poseida Therapeutics,Product:P-MUC1C-ALLO1 CAR-T ...,Indication:Breast Cancer,Ovarian Cancer,Lung Cancer, Search all connections |
Clinical trial Re-VOLVERe-VOLVE: A Phase II Clinical Trial in Women With Ovarian Cancer Progressing Post-PARP Inhibitor With Treatment Adapted to Real-time Assessment of Evolving Genomic Resistance Indication:Endometrial Cancer,Ovarian Cancer,Fallopian tube cance...,Drug:Atezolizumab,Tiragolumab,Organization:University Health Ne..., Search all connections |
Clinical trial AGO/2015/002Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer: A Randomized Phase II Trial Organization:University Hospital ...,Product:IPEC with Cisplatin,Indication:Ovarian Cancer,Primary Peritoneal C..., Search all connections |
Clinical trial 2020-A00036-33Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors |
Clinical trial NOGGO ov42Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients Organization:North Eastern German...,Product:Rucaparib,Placebos,Indication:Ovarian Cancer,Fallopian tube cance...,Primary Peritoneal C..., Search all connections |
Clinical trial ACCL0431A Randomized Phase III Study of Sodium Thiosulfate for the Prevention of Cisplatin-Induced Ototoxicity in Children Organization:Children's Oncology ...,Product:Sodium Thiosulfate,Indication:Brain Tumor,Central Nervous Syst...,Childhood Germ Cell ..., Search all connections |
Product Cediranib |
Clinical trial B2023-321-01An Open, Multicenter, Exploratory Clinical Study of Fluzoparib in Combination With Bevacizumab for Maintenance Therapy After First-line Platinum-containing Chemotherapy in BRCA Wild-type Advanced Ovarian Cancer Organization:Sun Yat-sen Universi...,Product:Fluzoparib,Indication:Ovarian Cancer,High Grade Serous Ad...,Endometrioid ovarian...,Drug:Atezolizumab, Search all connections |
Product celecoxibIndication:Colorectal Cancer,Breast Cancer,Fallopian tube cance...,Clinical trial:N202007026,0085-04-FB,03092, Search all connections |
Clinical trial NRG-GY019A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients With Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum Organization:NRG Oncology,Product:Carboplatin,Indication:Fallopian Tube Serou...,Low-grade serous ova...,Low Grade Serous Ade..., Search all connections |
Clinical trial MC1371Targeted Complex Therapy for Advanced Melanoma, Gynecologic Cancers, and Other Malignancies: Nab-Paclitaxel (Abraxane)/Bevacizumab Complex (AB-Complex) Organization:Mayo Clinic,Drug:Atezolizumab,Indication:Cervical Adenocarcin...,Cervical Adenosarcom...,Cervical Adenosquamo..., Search all connections |
Clinical trial PamiAPA Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor Exposure |
Clinical trial OZUHN-014Erdafitinib in Metastatic Steroid-cell Tumor of the Ovary, NOS Organization:University Health Ne...,Product:Erdafitinib,Indication:Ovarian Cancer,Steroid Cell Tumor,malignant, Search all connections |
Product N-Acetyl-CysteineIndication:Ovarian Cancer,Cognitive Impairment,Oral Mucositis Due t...,Clinical trial:20205846,2024-45, Search all connections |
Clinical trial NCI-2015-02064Phase 1 Dose Escalation and Expansion Cohort of Carboplatin and Gemcitabine With or Without M6620 (VX-970) in First or Second Recurrence Platinum-Sensitive Epithelial Ovarian, Peritoneal, and Fallopian Tube Cancer Organization:National Cancer Inst...,Product:Berzosertib,Indication:Fallopian Tube Carci...,Ovarian Cancer,Primary Peritoneal C..., Search all connections |
Clinical trial 2017-0671Clinical Study to Assess Efficacy and Safety of MDA-TIL (Autologous Expanded Tumor Infiltrating Lymphocytes) Across Multiple Tumor Types Organization:M.D. Anderson Cancer...,Product:Autologous Tumor Inf...,Indication:Malignant Solid Neop...,Colorectal Cancer,Ovarian Cancer, Search all connections |
Clinical trial NCI-2011-02500An Early Phase 1 Study of ABT-888 in Combination With Carboplatin and Paclitaxel in Patients With Hepatic or Renal Dysfunction and Solid Tumors Organization:National Cancer Inst...,Product:Carboplatin,Indication:Breast Cancer,Carcinoma of Unknown...,Endometrial Cancer, Search all connections |
Clinical trial 19-271ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study Organization:Memorial Sloan Kette...,Product:Indocyanine green dy...,Indication:Ovarian Cancer,Adnexal Mass, Search all connections |
Clinical trial OU-SCC-DURAFAKA Phase 2 Study of VS-6766 (Dual RAF/MEK Inhibitor) Plus Defactinib (FAK Inhibitor) in Recurrent Gynecological Cancers (DURAFAK) Organization:University of Oklaho...,Product:Avutometinib,Indication:Endometrioid Cancer,Ovarian Cancer,Cervical Cancer, Search all connections |
Product MOv19-BBz CAR T cellsIndication:Ovarian Cancer,Fallopian tube cance...,Primary Peritoneal C...,Clinical trial:830111 (UPCC-03818), Search all connections |
Product 6 cycles chemotherapyIndication:Retinoblastoma,Ovarian Cancer,Fallopian tube cance...,Clinical trial:yanghs20130507,NOGGO-ov53, Search all connections |
Product 3 cycles chemotherapyIndication:Retinoblastoma,Ovarian Cancer,Fallopian tube cance...,Clinical trial:yanghs20130507,NOGGO-ov53, Search all connections |
Clinical trial 830111 (UPCC-03818)Phase I Clinical Trial of Adoptive Transfer of Autologous Folate Receptor - Alpha Redirected T Cells for Recurrent High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Organization:University of Pennsy...,Product:MOv19-BBz CAR T cell...,Indication:Ovarian Cancer,Fallopian tube cance...,Primary Peritoneal C..., Search all connections |
Clinical trial 2016-0093Randomized Phase II Trial of Durvalumab (MEDI4736) and Tremelimumab Administered in Combination Versus Sequentially in Recurrent Platinum-Resistant Epithelial Ovarian Cancer Organization:M.D. Anderson Cancer...,Product:Durvalumab,Indication:Platinum-Resistant F...,Platinum-Resistant O...,Platinum-Resistant P..., Search all connections |
Clinical trial 2015-0520A Phase II Investigation of Bevacizumab for the Treatment of Second-Look Positive Epithelial Ovarian Cancer Organization:M.D. Anderson Cancer...,Product:Bevacizumab,Indication:Malignant Neoplasms ...,Ovarian Cancer,Fallopian tube cance...,Abstract:Utility of surgicall..., Search all connections |
Clinical trial FJ-OC-021Clinical Study of Fluzopalil Combined With Apatinib for Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian Cancer |
Clinical trial 2018-0775NOW: Neoadjuvant Olaparib Window Trial in Newly Diagnosed BRCA-Mutant Ovarian Cancer Organization:M.D. Anderson Cancer...,Drug:Cisplatin,Indication:Ovarian Carcinoma,BRCA1 Gene Mutation,BRCA2, Search all connections |
Clinical trial LCCC1818-ATLA Phase 1 Study of Autologous Activated T-cells Targeting the B7-H3 Antigen in Subjects With Recurrent Epithelial Ovarian Cancer Organization:UNC Lineberger Compr...,Product:CAR.B7-H3,Fludarabine,Cyclophosphamide,Indication:Ovarian Cancer, Search all connections |
Product RC48+carboplatin±bevacizumabIndication:Ovarian Cancer,fallopian tube carci...,Primary Peritoneal C...,Clinical trial:RCVDODIIR017, Search all connections |
Clinical trial RCVDODIIR017A Single-arm, Multicenter, Phase II Study of RC48 Plus Platinum With or Without Bevacizumab in the Treatment of HER-2 Expression Platinum-Sensitive Recurrent Ovarian Cancer Organization:Peking University Ca...,Product:RC48+carboplatin±bev...,Indication:Ovarian Cancer,fallopian tube carci...,Primary Peritoneal C..., Search all connections |
Clinical trial PROICM 2023-02 MROUnravelling Tumour Biology In Ovarian Cancer With Precision Imaging |
Clinical trial IRB-300005764Single-Arm Phase II Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer Who Are Folate Receptor α Positive Organization:University of Alabam...,Product:Mirvetuximab Soravta...,Indication:Ovarian Cancer,fallopian tube,Primary Peritoneal C..., Search all connections |
Clinical trial INSPIRE-001Investigator-initiated Phase II Study of Pembrolizumab Immunological Response Evaluation Organization:University Health Ne...,Product:Pembrolizumab,Indication:Squamous Cell Carcin...,Triple-Negative Brea...,Ovarian Cancer,Abstract:Comprehensive whole ..., Search all connections |
Product Fluzoparib+ApatinibIndication:Ovarian Cancer,High Grade Serous Ad...,Primary Peritoneal C...,Clinical trial:CS2023(166), Search all connections |
Clinical trial CS2023(166)A Randomized, Multicenter, Noncomparative Clinical Study of Fluzoparib With or Without Apatinib for Maintenance Therapy in PARPi-pretreated Platinum-sensitive Recurrent Ovarian Cancer Organization:Guangxi Medical Univ...,Product:Fluzoparib,Fluzoparib+Apatinib,Indication:Ovarian Cancer,High Grade Serous Ad...,Primary Peritoneal C..., Search all connections |
Clinical trial Zhengmao ZHANGA Prospective, Randomized Controlled Study of Cyclophosphamide, Bevacizumab With or Without Envafolimab in Recurrent Epithelial Ovarian Cancer (EOC), Fallopian Tube Cancer, and Primary Peritoneal Cancer |
Clinical trial 201-21-202Phase II Study Evaluating the Effect of IMNN-001 on Second Look Laparoscopy (SLL) in Combination With Bevacizumab (BEV) and Neoadjuvant Chemotherapy (NACT) in Newly Diagnosed With Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer Organization:Imunon,Drug:Tiragolumab,IMNN-001,Indication:Ovarian Cancer,Fallopian tube cance...,Primary Peritoneal C...,Product:Carboplatin,Bevacizumab, Search all connections |
Clinical trial CDR0000515008Phase I Trial of Intraperitoneal Administration of a) a CEA-Expressing Derivative, and b) a NIS-Expressing Derivative Manufactured From a Genetically Engineered Strain of Measles Virus in Patients With Recurrent Ovarian Cancer Organization:Mayo Clinic,Product:Carcinoembryonic ant...,oncolytic measles vi...,Reverse transcriptas...,Indication:Ovarian Cancer,Primary Peritoneal C..., Search all connections |
Clinical trial MMC-2014-17Phase II Randomized Study: Cytoreductive Surgery (CRS) With/Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Adjuvant Chemotherapy as Initial Treatment of Ovarian, Fallopian Tube, & Primary Peritoneal Cancer Organization:Mercy Medical Center,Product:Adjuvant Chemotherap...,Carboplatin,Indication:Stage III Ovarian Ca...,Ovarian Cancer,Fallopian tube cance..., Search all connections |
Clinical trial NCI-2011-03812GOG-0262: A Phase III Trial of Every-3-Weeks Paclitaxel Versus Dose Dense Weekly Paclitaxel in Combination With Carboplatin With or Without Concurrent and Consolidation Bevacizumab (NSC #704865) in the Treatment of Primary Stage II, III or IV Epithelial Ovarian, Peritoneal or Fallopian Tube Cancer and ACRIN 6695: Perfusion CT Imaging to Evaluate Treatment Response in Patients Participating in GOG-0262 Organization:National Cancer Inst...,Product:Bevacizumab,Indication:Endometrioid Adenoca...,Mucinous Adenocarcin...,Fallopian Tube Trans..., Search all connections |
Clinical trial HCC 21-162A Phase 2 Open-Label Study to Assess the Antitumor Activity of Neoadjuvant Chemotherapy With or Without HCW9218 in Patients With Metastatic Advanced Stage Ovarian Cancer |
Clinical trial NCI-2014-01118A Phase 1 Study of MLN0128 and Bevacizumab in Patients With Recurrent Glioblastoma and Other Solid Tumors Organization:National Cancer Inst...,Product:Bevacizumab,Indication:Glioblastoma,Endometrial Clear Ce...,Endometrial Serous A..., Search all connections |
Product NY-ESO-1Indication:Soft Tissue Sarcoma,Fallopian tube cance...,Ovarian Cancer,Clinical trial:TAEST16001 Phase II,CDR0000318803, Search all connections |
Clinical trial Uyar 25680 IIT MerckPhase II Open Label Nonrandomized Trial of the Anti PD 1 Therapy Pembrolizumab With First Line Platinum Based Chemotherapy Followed by 12 Months Pembrolizumab Monotherapy for Patients With Stage III/IV Epithelial Ovarian Cancer Organization:Medical College of W...,Product:Pembrolizumab,Carboplatin,Paclitaxel,Indication:Ovarian Cancer, Search all connections |
Clinical trial NOGGO S16/COMPASSComparison of Quality of Life (QoL) Between Trabectedin/PLD and Standard Platinum-based Therapy in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Peritoneal Cancer Organization:North Eastern German...,Product:Trabectidin,Indication:Quality of Life,Ovarian Cancer,Recurrent Ovarian Ca..., Search all connections |
Clinical trial GOG-3068GOG-3068: A Phase III Randomized Trial of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Cisplatin Versus no HIPEC at the Time of Optimal Interval Cytoreductive Surgery Followed by Niraparib Maintenance in Patients With Newly Diagnosed Stage III and IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer (Heated Ovarian Treatment Trial) Organization:GOG Foundation,Drug:Cisplatin,Indication:Stage III Ovarian Ca...,Ovarian Cancer,Stage III Primary Pe..., Search all connections |
Product LY4170156 |
Clinical trial ENGOT-OV64/NSGO-CTU-SOLEROAn Early Phase Randomized Trial of APX005M in BRCAwt Patients With Recurrent Ovarian Cancer |
Clinical trial LOXO-FRA-24001A First-in-Human, Phase 1a/1b Trial to Assess the Safety, Tolerability and Preliminary Efficacy of LY4170156, an Antibody-Drug Conjugate Targeting Folate Receptor α-Expressing Tumor Cells, in Participants With Selected Advanced Solid Tumors Organization:Eli Lilly and Compan...,Product:LY4170156,Indication:Ovarian Cancer,Endometrial Neoplasm...,Cervical Cancer, Search all connections |
Product Therapeutic autologous lymphocytesIndication:Fallopian tube cance...,Ovarian Cancer,Primary Peritoneal C...,Clinical trial:06-155,06-138, Search all connections |
Clinical trial 06-155A Phase I Dose Escalation Safety and Feasibility Study of WT1-Specific T Cells for the Treatment of Patients With Advanced Ovarian, Primary Peritoneal, and Fallopian Tube Carcinomas Organization:Memorial Sloan Kette...,Product:filgrastim,Therapeutic autologo...,Indication:Fallopian tube cance...,Ovarian Cancer,Primary Peritoneal C...,Drug:cyclophosphamide, Search all connections |
Clinical trial OZUHN-019Phase I Study of the PKMYT1 Inhibitor RP-6306 in Combination With Carboplatin and Paclitaxel for the Treatment of Recurrent TP53 Ovarian and Uterine Cancer Organization:University Health Ne...,Product:RP-6306,Carboplatin,Paclitaxel,Indication:Ovarian Cancer,Recurrent Uterine Ca...,Metastatic Cancer, Search all connections |
Clinical trial CASE2820Efficacy of Oral Regorafenib Combined With Intra-muscular Injection of Fulvestrant in Patients With Recurrent Low-grade Serous Ovarian Cancer: A Phase II Single Arm Trial |
Drug PEG-rhG-CSFIndication:Hematological Malign...,Chemotherapy,Ovarian Cancer,Clinical trial:2022-YAN-019,Abstract:Safety in the use of...,Safety and efficacy ..., Search all connections |
Drug Saruparib |
Drug IMNN-001Indication:Ovarian Cancer,Fallopian tube cance...,Primary Peritoneal C...,Abstract:A phase II study eva...,Clinical trial:201-21-202,201-17-201, Search all connections |
Drug VCN-01Indication:Retinoblastoma,Recurrent,Pancreatic Cancer,Abstract:VIRAGE: A phase IIb,...,Clinical trial:FSJD-RTB-2015,UPCC# 03821, IND #27..., Search all connections |
Drug ZEN003694Indication:Ovarian Cancer,Recurrent Solid Tumo...,Lung Cancer,Abstract:A phase 1 study of t...,Clinical trial:HCC 22-142, Search all connections |
Clinical trial SNB-101-101A Phase I, Open-Label, Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenously Infused SNB-101(as SN-38) in Patients With Advanced Solid Tumors Organization:SN Bioscience,Product:SNB-101,Indication:Colorectal Cancer,Breast Cancer,Pancreatic Cancer, Search all connections |
Clinical trial D6900C00001A Phase I/IIa Multi-center, Open-label Master Protocol to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Antitumor Activity of AZD8205 in Participants With Advanced or Metastatic Solid Malignancies Product:AZD8205,Indication:Breast Cancer,Cholangiocarcinoma,Ovarian Cancer,Organization:AstraZeneca, Search all connections |
Clinical trial TH1902-CTR-0001A Phase 1, Open-Label, Dose Escalation and Expansion Study of TH1902 in Patients With Advanced Solid Tumors Organization:Theratechnologies,Product:TH1902,Indication:Solid Tumor,Triple-Negative Brea...,Hormone Receptor-pos..., Search all connections |
Clinical trial OCEL-01A Phase 1b/2a Two-Part, Open-Label, Multicenter Study to Evaluate the Safety and Pharmacokinetics of OC-001 as Monotherapy and in Combination With an Anti-PD-1/Anti-PD-L1 Antibody in Patients With Selected Locally Advanced or Metastatic Cancers |
Product PF-07209960Indication:Non-small-cell Lung ...,Squamous Cell Carcin...,Renal Cell Carcinoma,Clinical trial:C4011001, Search all connections |
Clinical trial C4011001A PHASE 1 DOSE ESCALATION AND EXPANSION STUDY TO EVALUATE SAFETY, TOLERABILITY, PHARMACOKINETIC, PHARMACODYNAMIC, AND ANTI-TUMOR ACTIVITY OF PF-07209960 IN PARTICIPANTS WITH ADVANCED OR METASTATIC SOLID TUMORS Organization:Pfizer,Product:PF-07209960,Indication:Non-small-cell Lung ...,Squamous Cell Carcin...,Renal Cell Carcinoma, Search all connections |
Clinical trial APG2449XC101A Phase I Study of the Safety, Pharmacokinetic and Pharmacodynamic Properties of Orally Administered APG-2449 in Patients With Advanced Solid Tumors Organization:Ascentage Pharma Gro...,Product:APG-2449,Indication:Solid Cancer,Lung Cancer,Esophageal cancer,Clinical trial arm:arm_1, Search all connections |
Clinical trial ZN-c3-002A Phase 1b Study of ZN-c3 in Combination With Chemotherapy in Patients With Platinum-Resistant Ovarian, Peritoneal or Fallopian Tube Cancer Organization:K-Group Beta,Product:Carboplatin,Paclitaxel,ZN-c3,Indication:Solid Tumor,Ovarian Cancer,Fallopian tube cance..., Search all connections |
Clinical trial ROOTThe Registry of Oncology Outcomes Associated With Testing and Treatment (ROOT) Organization:Taproot Health,Product:Systemic Treatment,Indication:Adenocarcinoma,Adenoid Cystic Carci...,Anal Cancer, Search all connections |
Clinical trial FPI-1966-101A Phase 1/2 Study of [225Ac]-FPI-1966, [111In]-FPI-1967, and Vofatamab in Participants With FGFR3-expressing Advanced, Inoperable, Metastatic and/or Recurrent Solid Tumours |
Clinical trial SC0191-102A Phase Ib/II Clinical Study on the Safety, Pharmacokinetic Characteristics, and Preliminary Efficacy of SC0191 Combination Chemotherapy in Patients With Advanced Ovarian Cancer. Organization:Biocity Biopharmaceu...,Product:SC0191,Gemcitabine,Paclitaxel,Indication:Ovarian Cancer, Search all connections |
Clinical trial 1775-004A Randomized, Phase II Study Evaluating MK-1775 in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone in Adult Patients With Platinum Sensitive p53 Mutant Ovarian Cancer |
Clinical trial BR55-108BR55 Contrast Enhanced Ultrasound (CEUS) in Characterization of Ovarian Lesions |
Clinical trial IMX-110-001A Phase 1/2a Open-Label, Dose-Escalation/Dose-Expansion Safety, Tolerability and Pharmacokinetic Study of IMX-110 in Patients With Advanced Solid Tumors |
Clinical trial GCT1021-01First-in-human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety of Axl-specific Antibody-drug Conjugate (Enapotamab Vedotin, HuMax®-AXL-ADC) in Patients With Solid Tumors Organization:Genmab,Product:Enapotamab vedotin,Indication:Ovarian Cancer,Cervical Cancer,Endometrial Cancer, Search all connections |
Clinical trial NIR-OGT-201A Phase 2 Trial of Nirogacestat in Patients With Recurrent Ovarian Granulosa Cell Tumors Product:Nirogacestat,Indication:Ovarian Granulosa St...,Granulosa Cell Tumor,Ovarian Cancer,Organization:SpringWorks Therapeu..., Search all connections |
Clinical trial KCSG GY20-10Phase 1b/2, Single Arm Clinical Trial to Evaluate the Safety and Activity of Oregovomab and Bevacizumab, Paclitaxel Carboplatin as a Combinatorial Strategy in Subjects With BRCA-wild Type Platinum Sensitive Recurrent Ovarian Cancer Organization:CanariaBio,Product:Oregovomab,Bevacizumab,Paclitaxel,Indication:Ovarian Cancer by FI...,Ovarian Cancer,Stage IV Ovarian Can..., Search all connections |
Clinical trial AK112-203Phase II Study of AK112 (Anti-PD-1 and VEGF Bi-specific Antibody) in the Treatment of Advanced Gynecological Carcinoma |
Clinical trial CPI-006-001A PHASE 1/1b MULTICENTER STUDY TO EVALUATE THE HUMANIZED ANTI-CD73 ANTIBODY, CPI-006, AS A SINGLE AGENT OR IN COMBINATION WITH CIFORADENANT, WITH PEMBROLIZUMAB, AND WITH CIFORADENANT PLUS PEMBROLIZUMAB IN ADULT SUBJECTS WITH ADVANCED CANCERS Organization:Corvus Pharmaceutica...,Product:CPI-006,Indication:Renal Cell Cancer,Colorectal Cancer,Triple-Negative Brea..., Search all connections |
Clinical trial 213350A Randomized, Double-blind, Phase 3 Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer Organization:Tesaro,Product:Dostarlimab,Niraparib,Standard of care,Indication:Ovarian Cancer,Ovarian,Fallopian Tube and P..., Search all connections |
Clinical trial B7391012A Prospective, Single-arm, Open-label, Non-interventional, Multicenter, Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Non-small Cell Lung Cancer, Metastatic Colorectal Cancer, Metastatic Breast Cancer, Advanced or Metastatic Kidney Cancer, Cervical Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer or Glioblastoma Multiforme. |
Clinical trial D0817R00019A Pan-European Non-interventional, Retrospective Observational Cohort Study of Patients With BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian Cancer Treated With Olaparib Tablets in the First-line Maintenance Setting |
Clinical trial AL3818-US-002A Phase 1/2a/3 Evaluation of the Safety and Efficacy of Adding AL3818 (Anlotinib, INN: Catequentinib), a Dual Receptor Tyrosine Kinase Inhibitor, to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma Organization:Advenchen Laboratori...,Product:Paclitaxel,AL3818,Indication:Endometrial Cancer,Ovarian Cancer,fallopian tube carci..., Search all connections |
Clinical trial TJ004309STM103A Phase 2 Clinical Study of TJ004309 in Combination With Atezolizumab (TECENTRIQ®) in Patients With Advanced or Metastatic Ovarian Cancers and Selected Advanced Solid Tumors Organization:I-Mab Biopharma US,Product:TJ004309,Indication:Ovarian Cancer,Head and Neck Cancer,Lung Cancer, Search all connections |
Clinical trial PBC052A Phase I Clinical Study to Assess the Safety and Efficacy of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors Organization:Chongqing Precision ...,Product:CD70 CAR-T cells,Indication:Renal Cell Carcinoma,Ovarian Cancer,Cervical Cancer, Search all connections |
Clinical trial FZPL-Ⅰ-120A Phase I, Multi-center Study to Determine the Effect of Fluzoparib on Pharmacokinetics of Caffeine, S-Warfarin, Omeprazole, Midazolam, Repaglinide and Bupropion in Patients With Recurrent Ovarian Cancer |
Clinical trial BGB149-102Phase 1b, Multicentre, Multiple Ascending Dose, Safety, Pharmacokinetic, and Pharmacodynamic Study of Tilvestamab (BGB149) in Relapsed, Platinum-resistant, High-grade Serous Ovarian Cancer (HGSOC) Patients |
Clinical trial INCB 01158-203A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of INCB001158 in Combination With Chemotherapy, in Subjects With Advanced or Metastatic Solid Tumors Product:INCB001158,Indication:Biliary Tract Cancer,Colorectal Cancer,Endometrial Cancer,Organization:Incyte, Search all connections |
Clinical trial CUE-102-01A Phase 1, Open-Label, Dose Escalation and Expansion Study of CUE-102 Monotherapy in HLA-A*0201 Positive Patients With WT1 Positive Recurrent/Metastatic Cancers Organization:Cue Biopharma,Product:CUE-102,Indication:Colorectal Cancer,Stomach Cancer,Pancreatic Cancer,Abstract:A phase 1, open-labe..., Search all connections |
Clinical trial ARC-5 (AB928CSP0005)A Phase 1 Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies |
Clinical trial VISTA-101A Phase 1/2 Open-label Trial of KVA12123 Alone and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors |
Clinical trial 7339-001A Randomized Phase 3, Double-Blind Study of Chemotherapy With or Without Pembrolizumab Followed by Maintenance With Olaparib or Placebo for the First-Line Treatment of BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (KEYLYNK-001 / ENGOT-ov43 / GOG-3036) Organization:Merck Sharp & Dohme,Product:Olaparib,Bevacizumab,Pembrolizumab,Indication:Ovarian Cancer,Fallopian tube cance...,Peritoneal Neoplasms, Search all connections |
Product AMT-151 |
Clinical trial AMT-151-01First-in-Human, Phase 1 Study of AMT-151, an Anti-Folate Receptor Alpha Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours |
Clinical trial BR55-109An Exploratory Study to Determine the Optimal Timing of BR55 Contrast Enhanced Ultrasound (CEUS) of the Ovaries in Pre-menopausal Women |
Clinical trial KAN0007KANDOVA - A Two-Part Phase Ib/IIa Study to Evaluate the Safety and Tolerability of KAND567, in Combination With Carboplatin Therapy, and to Determine the Recommended Phase II Dose (RPIID) of KAND567: An Open-Label, Multicenter Dose Escalation Study With an Expansion Cohort in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Product:KAND567,Carboplatin,Indication:Ovarian Cancer,Fallopian tube cance...,Peritoneal Cancer,Organization:Kancera, Search all connections |
Clinical trial PN-201-22A Randomized Phase 2 Study to Evaluate the Efficacy and Safety for Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian Cancer (Cornerstone-004) |
Clinical trial 0739-CL-0101A Phase 1/2 Open-label Study Investigating the Safety, Tolerability and Efficacy of ASP0739 as a Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors Known to Express NY-ESO-1 Organization:Astellas Pharma Glob...,Product:Pembrolizumab,ASP0739,Indication:Ovarian Cancer,NSCLC,ESCC, Search all connections |
Clinical trial EP0057-201Phase 2 Study to Evaluate the Safety & Efficacy of EP0057 in Combination With Olaparib in Advanced Ovarian Cancer Patients Who Have: Cohort 1 - Platinum Resistant Disease; Cohort 2 - Had at Least 1 Prior Line of Therapy Which Must Include at Least 1 Line of Platinum-based Chemotherapy Followed by PARP Inhibitor Maintenance |
Product NI-1801Indication:Ovarian Cancer,Triple-Negative Brea...,Non-squamous non-sma...,Clinical trial:LCB-1801-001, Search all connections |
Clinical trial LCB-1801-001A Phase 1, Open-label, Dose Finding Study of NI-1801, a Bispecific Mesothelin x CD47 Engaging Antibody, in Patients With Mesothelin Expressing Solid Cancers Organization:Light Chain Bioscien...,Product:NI-1801,Indication:Ovarian Cancer,Triple-Negative Brea...,Non-squamous non-sma..., Search all connections |
Clinical trial XL184-021A Phase 1b Dose-Escalation Study of Cabozantinib (XL184) Administered Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Product:cabozantinib,Organization:Exelixis,Indication:Bladder Cancer,Renal Cell Carcinoma,Castration-resistant..., Search all connections |
Product E7449Indication:Malignant Solid Tumo...,Ovarian Cancer,Triple-Negative Brea...,Clinical trial:E7449-E044-101, Search all connections |
Clinical trial EC20.1CLINICAL STUDY OF A SINGLE-CENTER CLINICAL STUDY TO EVALUATE THE SAFETY AND BIODISTRIBUTION OF TECHNETIUM Tc 99m EC20 IN NORMAL VOLUNTEERS AND OVARIAN CANCER PATIENTS |
Product AZD 1775Indication:Ovarian Cancer,Triple-negative brea...,small cell lung canc...,Clinical trial:D6015C00001, Search all connections |
Clinical trial E7449-E044-101An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors Product:E7449,Indication:Malignant Solid Tumo...,Ovarian Cancer,Triple-Negative Brea...,Organization:Eisai, Search all connections |
Clinical trial D6015C00001A Phase Ib, Open-Label, Multi-Centre Study to Assess the Safety, Tolerability, Pharmacokinetics, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours Product:AZD 1775,Indication:Ovarian Cancer,Triple-negative brea...,small cell lung canc...,Organization:AstraZeneca, Search all connections |
Clinical trial ULI-EAP-100Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies Organization:xCures,Product:Ulixertinib,Indication:Pancreatic Cancer,Small Intestine Canc...,Colorectal Cancer, Search all connections |
Product rhuGM-CSFIndication:Breast Cancer,Stomach Cancer,Ovarian Cancer,Clinical trial arm:arm_1,arm_1,arm_1,Clinical trial:PN-301-22, Search all connections |
Clinical trial CLXH254X2101A Phase I Dose Finding Study of Oral LXH254 in Adult Patients With Advanced Solid Tumors Harboring MAPK Pathway Alterations Organization:Novartis Pharmaceuti...,Product:PDR001,LXH254,Indication:NSCLC,Ovarian Cancer,Melanoma, Search all connections |
Clinical trial M13-694A Phase 3 Placebo-Controlled Study of Carboplatin/Paclitaxel With or Without Concurrent and Continuation Maintenance Veliparib (PARP Inhibitor) in Subjects With Previously Untreated Stages III or IV High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Organization:AbbVie,Product:Paclitaxel,Veliparib,Carboplatin,Indication:Ovarian Cancer,Ovarian Carcinoma, Search all connections |
Clinical trial BXU572940A Randomized, Multi-center, Cross-over, Comparative Bioavailability Study of DOXIL/CAELYX Manufactured at a New Site in Patients With Advanced or Refractory Ovarian or Breast Cancer Organization:Baxter Healthcare,Product:DOXIL/CAELYX,Indication:Ovarian Cancer,AIDS-related Kaposi ...,Multiple Myeloma, Search all connections |
Clinical trial ARC-2 (AB928CSP0002)A Phase 1/1b Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Breast or Gynecologic Malignancies Product:Etrumadenant,Pegylated liposomal ...,IPI-549,Indication:Triple-Negative Brea...,Ovarian Cancer,Organization:Arcus Biosciences, Search all connections |
Clinical trial BO41929A Phase II, Open-Label, Single Arm Decentralized Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors |
Clinical trial EC20.2A Multi-center Clinical Study to Evaluate the Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer |
Clinical trial FT536-101A Phase I, Open-Label, Multicenter Study of FT536 as Monotherapy and in Combination With Monoclonal Antibodies in Subjects With Advanced Solid Tumors Organization:Fate Therapeutics,Product:FT536,Indication:Lung Cancer,Colorectal Cancer,Breast Cancer, Search all connections |
Clinical trial Niraparib-4001Zedula Special Drug Use Observational Study "Ovarian Cancer" |
Clinical trial PROC0319Open Label Randomized Clinical Study of Plasmid Encoding p62/SQSTM1 (ELenagen) in in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer Organization:CureLab Oncology,Product:Gemcitabine,ELENAGEN,Indication:Ovarian Cancer,Platinum-resistant O..., Search all connections |
Clinical trial PBC037A Phase I Clinical Study of CD70-targeting CAR-T Therapy in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors Organization:Chongqing Precision ...,Product:CD70 CAR-T cells,Indication:Metastatic Tumor,Advanced Solid Tumor,Renal Cell Carcinoma, Search all connections |
Clinical trial QBS-72S-1001A Phase 1, Open Label, Multi-Center, Single and Multiple Dose, Dose Escalation and Expansion Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S in Previously Treated Patients With Advanced or Metastatic Cancers With High LAT1 Signatures, and in Patients With Relapsed or Refractory Grade 4 Astrocytoma Organization:Quadriga Biosciences,Product:QBS10072S,Indication:Astrocytoma,Brain Cancer,Brain Metastases, Search all connections |
Clinical trial C5331001A PHASE 1, OPEN-LABEL, MULTICENTER, DOSE ESCALATION AND DOSE EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND ANTITUMOR ACTIVITY OF PF-07224826, AS A SINGLE AGENT AND IN COMBINATION WITH ENDOCRINE THERAPY IN PARTICIPANTS WITH ADVANCED SOLID TUMORS Organization:Pfizer,Product:Fulvestrant,PF-07224826,Indication:Breast Cancer,Ovarian Cancer,Liposarcoma, Search all connections |
Clinical trial B9991009A PHASE 3, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY OF AVELUMAB (MSB0010718C) ALONE OR IN COMBINATION WITH PEGYLATED LIPOSOMAL DOXORUBICIN VERSUS PEGYLATED LIPOSOMAL DOXORUBICIN ALONE IN PATIENTS WITH PLATINUM-RESISTANT/REFRACTORY OVARIAN CANCER |
Clinical trial EDO-S101-1002A Phase 1/2 Study to Investigate the Safety, Pharmacokinetics and Efficacy of EDO-S101, a First-in-Class Alkylating Histone Deacetylase Inhibition (HDACi) Fusion Molecule, in Patients With Advanced Solid Tumors Organization:Mundipharma Research,Product:Tinostamustine,Indication:Small Cell Lung Canc...,Soft Tissue Sarcoma,Triple-negative Brea...,Abstract:A phase II study of ..., Search all connections |
Clinical trial CCT303-406-mST01A Phase I Trial to Assess Safety, Tolerability and Anti-tumor Activity of Autologous T Cell Modified Chimeric Antigen Receptor (CAR) (CCT303-406) in Patients With Relapsed or Refractory HER2 Positive Solid Tumors Organization:Shanghai PerHum Ther...,Product:CCT303-406,Indication:Solid Tumor,Stomach Cancer,Breast Cancer, Search all connections |
Clinical trial D6015C00003A Phase Ib Study to Determine the Maximum Tolerated Dose (MTD) of AZD1775 Monotherapy in Patients With Locally Advanced or Metastatic Solid Tumours. Organization:AstraZeneca,Product:AZD1775,Indication:Locally Advanced Sol...,Metastatic Solid Tum...,Ovarian Cancer, Search all connections |
Clinical trial AK112-204Phase Ib/II Clinical Study of Anti-PD-1 and VEGF Bispecific Antibody (AK112) Combined With PARP Inhibitor in the Treatment of Recurrent Ovarian Cancer Organization:Akeso,Product:AK112,Indication:Ovarian Cancer,Recurrent Ovarian Ca...,Relapsed Ovarian Can..., Search all connections |
Clinical trial CDX527-01A Phase 1 Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies |
Clinical trial SGNTV-002Open Label Phase 2 Study of Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With a Safety Run-in of a Dose-Dense Regimen Product:Tisotumab Vedotin,Indication:Ovarian Cancer,Fallopian tube cance...,Peritoneal Cancer,Organization:Seagen, Search all connections |
Clinical trial AMXT1501-102A Phase 1B/2A Study of the Safety, Tolerability and Initial Efficacy of Oral AMXT 1501 Dicaprate and Intravenous Difluoromethylornithine (DFMO) in Patients With Cancer |
Clinical trial 21-VIN-0166/SAN-0647A Randomized, Open Label, Multi-centre, Two-treatment, Two-period, Two-sequence, Two-stage, Multiple Dose, Steady-state, Crossover, Bioequivalence Study of Olaparib Tablets, 150 mg (Lek Pharmaceuticals d.d.) and Lynparza® (Olaparib) Tablets 150 mg (AstraZeneca Pharmaceuticals LP), in Patients With BRCA Mutated Ovarian Cancer, Recurrent Ovarian Cancer or Metastatic Breast Cancer Under Fasting Condition |
Clinical trial EC20.4A MULTI-CENTER CLINICAL STUDY TO EVALUATE THE SAFETY AND EFFICACY OF FOLATESCAN (TECHNETIUM Tc 99m EC20) IN PATIENTS WITH SUSPECTED OVARIAN CARCINOMA OR RECURRENT ENDOMETRIAL CARCINOMA |
Clinical trial RAIN-3202A Phase 2 Basket Study of Milademetan in Advanced/Metastatic Solid Tumors (MANTRA-2) Organization:Rain Oncology,Product:RAIN-32,Indication:Solid Tumors,Head and Neck Carcin...,Cholangiocarcinoma, Search all connections |